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Accumulating evidence suggests that aerobic exercise benefits cerebrovascular hemodynamics 
and arterial stiffness. Few studies have evaluated acute effects of aerobic exercise on cerebral 
blood flow and even fewer on cerebral pulsatile flow. Furthermore, it has been proposed that 
cerebral blood flow is more pulsatile with higher arterial stiffness, though little is known about 
this relationship, particularly in response to exercise. PURPOSE: To evaluate acute effects of 
aerobic exercise on cerebrovascular hemodynamics and arterial stiffness. METHODS: Fifteen 
middle-aged adults were recruited for this randomized crossover study comprised of three 
experimental visits: 30 minutes of sitting (SIT), 20 minutes of sitting followed by a 10-minute 
exercise bout (EX10), and a 30-minute exercise bout (EX30). Cerebrovascular hemodynamics 
and arterial stiffness were measured before the experimental session and at 30- and 60-minute 
post-session. Cerebrovascular hemodynamics were measured using Transcranial Doppler 
ultrasonography at the middle cerebral artery (MCA). Arterial stiffness was measured by pulse 
wave velocity (cfPWV and crPWV) and pulse pressure. RESULTS: Pulsatility index was 
marginally higher in EX30 versus SIT (4.7%, P=0.08) at the 30-minute post-session assessment. 
Cerebrovascular blood flow velocity was not different across conditions (P>0.10). Pulse pressure 
was lower in EX10 (β =-2.79 mmHg, P=0.01) and in EX30 (β=-3.85 mmHg, P=0.001) versus 
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SIT at the 60-minute post-session assessment. Neither cfPWV nor crPWV were different from 
SIT following EX30 (P>0.05). However, compared to SIT, cfPWV was higher in EX10 at the 
30-minute post-session assessment (β =0.30 m/s, P=0.02) and crPWV was lower in EX10 at the 
60-minute post-session assessment (β =-0.88 m/s, P=0.004). Neither changes in cfPWV nor 
crPWV were associated with changes in cerebral pulsatile flow (P>0.05). Higher pulse pressure 
was associated with higher cerebral pulsatile flow (β =0.004, P=0.02) at the 30- but not the 60-
minute post-session assessment. CONCLUSIONS: Based on our results, aerobic exercise does 
not improve cerebrovascular hemodynamics in the MCA within an hour of aerobic exercise. 
Future research should include more frequent and longer post-exercise observation periods, 
different cerebral regions and vessels, and relationships with arterial stiffness. Additionally, our 
results suggest 10- and 30-minute exercise bouts have differential effects on PWV which also 
warrants further research. 
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1.0  INTRODUCTION 
1.1 BACKGROUND 
Cerebrovascular aging is associated with adverse structural and functional changes in the brain 
such as impairment of vascular function and reduced cerebral blood flow (CBF) [1, 2]. Reduced 
CBF can lead to serious consequences owing to the brain’s critical need for constant blood flow. 
Since the brain lacks energy stores, neurons are dependent on adequate blood flow to provide 
nutrients and oxygen as well as remove waste for proper brain function. When blood flow is 
unable to meet the increased neuronal metabolic needs, neural dysfunction and subsequent 
disease can occur. These adverse alterations in cerebrovascular hemodynamics and reduced 
cerebrovascular function are associated with cognitive decline, increased risk of stroke and 
neurodegenerative disorders (e.g., Alzheimer’s and Parkinson’s diseases), as well as premature 
mortality [1].  Systemic increases in arterial stiffness are thought to contribute to impaired 
cerebrovascular hemodynamics. Specifically, these systemic vascular changes can lead to similar 
adverse changes in cerebral arteries including increases in stiffness, reduced CBF and pulsatile 
blood flow (i.e., blood flow with large fluctuations between systole and diastole that can be 
harmful to arteries)  [3, 4] . Both cross-sectional and longitudinal studies have established these 
associations between central, peripheral, and cerebral blood vessels [4-6].   
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Healthy elastic central arteries (e.g., the aorta and carotid artery) expand and recoil to 
cushion the pulsatile blood flow generated by the left ventricle of the heart and allow for 
continuous, relatively non-pulsatile blood flow to reach the peripheral organs (e.g., the brain) [3, 
6] . With increasing age or the presence of cardiovascular risk factors, central arteries stiffen and 
are less capable of cushioning pulsatile flow. This results in increased pulsations and pressure 
gradients in central arteries, which in turn exposes the delicate, more distal microvasculature of 
the brain to the same potentially harmful flow patterns [7]. Since the brain demands a high blood 
flow to function [1, 8], and has low vascular resistance, cerebral arteries are particularly 
vulnerable to such flow patterns and can be damaged when exposed to high pulsatile flow that 
has not been cushioned by the supplying arteries [9].  Increased cerebral pulsatile blood flow is 
linked to ruptures of small vessels, leading to lesions in the white matter [5], thus increasing the 
risk of stroke [7, 10], cognitive decline, dementia [11] and Alzheimer’s disease [12]. Considering 
the deleterious consequences of pulsatile blood flow in the cerebral vessels, and the established 
associations between arterial stiffness and cerebral pulsatile blood flow, interventions targeting 
decreased arterial stiffness could be a potential method for improving cerebrovascular function. 
Physical activity is known to reduce arterial stiffness resulting in an improved ability of 
the arteries to expand and recoil [13]. Consequently, the arteries are thought to be better able to 
buffer pulsatile flow, preventing such flow from reaching the brain. Further, physical activity is 
known to improve vascular function (e.g., endothelial function) and this leads to improved CBF 
and decreased cerebrovascular disease [14]. Therefore, physical activity may improve 
cerebrovascular hemodynamics, in part through systemic decreases in arterial stiffness [3]. 
However, cerebrovascular hemodynamics and the impact of changes in arterial stiffness 
following acute aerobic exercise have not been well established.  
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The American College of Sports Medicine recommends participating in moderate-
intensity physical activity for 30 minutes per day for a total of 150 minutes per week in bouts of 
at least 10 continuous minutes [15, 16].  A single 30-minute bout of aerobic exercise has been 
shown to acutely reduce arterial stiffness [17]. Though recommended as the minimum duration 
for health benefits, the acute effects of a 10-minute exercise bout on arterial stiffness have not 
been evaluated. Furthermore, though cross-sectional studies have associated arterial stiffness 
with cerebrovascular hemodynamics [5, 18], it is unclear whether a single bout of exercise 
improves cerebral pulsatile blood flow or whether such improvements track with the effects of 
exercise on arterial stiffness. 
1.2 SPECIFIC AIMS 
Specific Aim I:  Compare 1-hour trajectories of cerebrovascular pulsatile blood flow after 3 
conditions: rest, 10-minute aerobic exercise and 30-minute aerobic exercise. 
Specific Aim II:  Compare 1-hour trajectories of peak systolic, mean, and end diastolic blood 
flow after 3 conditions: rest, 10-minute aerobic exercise and 30-minute aerobic exercise. 
Specific Aim III:  Compare 1-hour trajectories of arterial stiffness (measured by pulse wave 
velocity and pulse pressure) after 3 conditions: rest, 10-minute aerobic exercise and 30-minute 
aerobic exercise. 
Specific Aim IV:  Evaluate whether changes in arterial stiffness are related to changes in 
cerebral pulsatile blood flow over 1-hour trajectories after the 3 conditions. 
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1.3 HYPOTHESES 
We hypothesized that cerebrovascular hemodynamics would improve in a dose-response manner 
following a single bout of exercise.  Specifically, we expected a 10-minute exercise bout to result 
in improvements over rest and for a 30-minute exercise bout to result in improvements over rest 
and a 10-minute bout. We hypothesized that arterial stiffness (as measured by pulse wave 
velocity and pulse pressure) would improve in a similar manner. Further, we hypothesized that 
improvements in cerebrovascular hemodynamics would occur concurrently with changes in 
arterial stiffness that result from a single bout of exercise. In other words, changes in arterial 
stiffness would be related to changes in cerebrovascular hemodynamics, and particularly cerebral 
pulsatile blood flow. 
1.4 THEORETICAL FRAMEWORK 
Figure 1 illustrates the aims of the study which evaluated whether single bouts of exercise of 
different durations (10-minute and 30-minute bout) could elicit improvements in cerebrovascular 
hemodynamics (Aims I and II) and arterial stiffness (Aim III). Additionally, this study examined 
whether reductions in arterial stiffness explain improvements in cerebrovascular hemodynamics 
(Aim IV). As noted in the figure, this study investigated several novel effects and relationships 
(noted by single arrows) and built upon known acute effects of 30 minutes of exercise on arterial 
stiffness (double arrow). 
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Figure 1 Theoretical Framework of the Acute Effects of a Single Bout of Exercise 
Single arrows denote unknown relationships while double arrows denote relationships that  
have already been studied. 
1.5 SIGNIFICANCE  
The present study aimed to address whether aerobic exercise can acutely improve 
cerebrovascular hemodynamics and provide better insight into the relationship between 
cerebrovascular health and systemic vascular health. Specifically, we examined cerebrovascular 
health as measured by cerebrovascular blood flow and pulsatile flow in the middle cerebral 
artery as it relates to arterial stiffness as measured by pulse pressure and pulse wave velocity.  
These results shed light on whether cerebrovascular hemodynamics respond as acutely to 
exercise as arterial stiffness. Further, we evaluated whether a shorter 10-minute bout is sufficient 
to elicit these beneficial changes in cerebral and systemic vascular function. These research 
questions address a gap in the literature regarding the acute time course and dose-response 
relationship of exercise-induced improvements in arterial stiffness and cerebrovascular 
hemodynamics. Further, this research provides insight into the mechanisms through which acute 
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benefits accumulated via habitual exercise could reduce the risk of cerebrovascular disease and 
improve cerebrovascular function.  
Additionally, if bouts of exercise lasting 10 or 30 minutes have beneficial effects on 
cerebrovascular hemodynamics, these results would support the American College of Sports 
Medicine recommendation of participating in physical activity for 30 minutes on most days of 
the week in bouts lasting at least 10 continuous minutes to meet a goal of 150 minutes per week 
(rather than reaching this goal over a couple of days). If beneficial effects are only observed after 
longer, 30-minute bouts, this would inform exercise interventions with the aim of improving 
cerebrovascular health to not recommend 10-minute exercise bouts, but rather longer bouts for 
acute benefits. 
Lastly, this study serves as a foundation for future research. Future studies could 
investigate the effects of longer bouts of exercise, different modes and intensities. Additionally, 
future studies could explore acute changes in cerebral microvasculature. Further research could 
evaluate if improvements in cerebrovascular hemodynamics are related to acute improvements in 
cognition known to occur following an exercise bout.  Also, future studies could examine 
whether longer term exercise training improves cerebrovascular hemodynamics and evaluate 
associations between chronic adaptations in cerebrovascular hemodynamics and arterial stiffness  
that result from an exercise intervention. 
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2.0  REVIEW OF LITERATURE 
2.1 CEREBROVASCULAR HEALTH 
2.1.1 Cerebrovascular circulation 
The brain is one of the most highly perfused organs in the body [19] due to its high metabolism 
and lack of energy stores.  Though the brain only makes up 2% of total body mass, it receives 
20% of cardiac output, consumes 20% of the body’s oxygen supply and 25% of the body’s 
glucose [20]. Neurons are dependent on blood vessels to provide oxygen and nutrients, as well as 
to remove carbon dioxide and waste for normal function [1]. Neural activation elicits local 
increases in blood flow to support increased neural metabolism (functional hyperemia) and thus 
continuous CBF is critical [8]. In fact, the brain has several protective mechanisms to ensure that 
the brain has sufficient blood flow providing needed nutrients and energy metabolites. These 
mechanisms include neurovascular coupling, the blood brain barrier, autoregulation, and 
collateral blood flow. 
Neurovascular coupling is the primary mechanism to ensure adequate nutrient supply to 
the brain. It occurs via an intricate network of vascular cells (endothelium, pericytes, vascular 
smooth muscle cells), glial cells (astrocytes and microglia) and neurons that form the 
neurovascular unit [1, 8].  Proper cell to cell signaling and interaction is necessary for 
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neurovascular coupling to occur. For example, neurotransmitters and mediators released from 
neurons indirectly alter blood vessel tone through activation of vascular smooth muscle cells and 
astrocytes [21]. Specifically, the release of glutamate (the main neurotransmitter in the brain) 
results in upregulation of nitric oxide (NO) synthase. Greater NO synthase leads to the release of 
neuronal NO and astrocyte arachidonic acid, which results in vasodilation and an increase in 
cerebral blood flow, thereby meeting increased neuronal metabolic needs [22].  
Another mechanism to ensure sufficient nutrient delivery is the blood brain barrier. The 
neurovascular unit endothelial cells together form a “highly specialized” membrane around 
blood vessels which underlines the blood brain barrier. This is a selective barrier that regulates 
the delivery of energy metabolites and nutrients and prevents potentially neurotoxic and 
vasculotoxic molecules from entering into the central nervous system [1].  Thus, the integrity of 
this barrier is crucial for normal neuronal and synaptic function. 
Autoregulation is another important protective mechanism to ensure constant cerebral 
blood flow. Autoregulation refers to the intrinsic property of the cerebral blood vessels to 
maintain flow at approximately 50 mL per 100 g of brain tissue per minute despite changes in 
mean arterial pressure within 60 mmHg and 150 mmHg. This occurs through cerebrovascular 
reserve (measured by vasoreactivity), which is the ability of cerebral blood vessels to respond to 
increased metabolic demand and other chemical or mechanical stimuli [8]. Thus, cerebral 
autoregulation is dependent upon the vasculature’s ability to vasoconstrict and vasodilate to 
maintain constant cerebral blood flow. 
Yet another mechanism to ensure constant blood flow is a circulatory anastomosis (cross 
connection) of cerebral blood vessels called the Circle of Willis. The Circle of Willis typically 
contains vessels which allow for collateral blood flow between the cerebral hemispheres. The 
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arterial blood supply to the brain typically consists of two internal carotid and two vertebral 
arteries. The vertebral arteries join to form the basilar artery, which then anastomoses with the 
internal carotid arteries via the posterior communicating arteries, forming this anastomotic ring 
at the base of the brain [19, 20].  The Circle of Willis allows for blood to flow to compensate for 
a lack of blood flow in one brain region in the event of a blockage. Each of the internal carotid 
arteries provide approximately 40% of blood flow to the brain and give rise to the middle 
cerebral artery (MCA) and the anterior cerebral artery, which mainly supply the cerebrum. The 
basilar artery provides the remaining 20% of blood flow and gives rise to the posterior cerebral 
arteries, which mainly supply the cerebellum and brain stem [19]. The middle, anterior and 
posterior cerebral arteries divide into increasingly smaller arteries and arterioles until they reach 
the brain tissue to supply blood to neurons in their respective regions.   
 These mechanisms work together so that the brain receives sufficient blood flow to 
support neural metabolism and prevent neuronal damage that could occur from toxic molecules 
and fluctuations in blood flow or mean arterial pressure. They also highlight the importance of 
cerebrovascular function in normal brain function.  The following sections describe how aging 
and disease can impair these protective mechanisms and lead to maladaptive cerebrovascular 
hemodynamics and reduced brain function. 
2.1.2 Cerebrovascular aging 
Aging is associated with changes in cerebral hemodynamics. Specifically, changes include 
decreases in resting CBF and increases in pulsatile flow [23]. After the third decade, CBF 
declines by approximately 4 mL min-1 yr-1 [24].  These age-related decreases in blood flow occur 
in both the major cerebral arteries and in regional cerebral perfusion [23, 25]. Though the 
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underlying mechanisms have yet to be elucidated, structural changes in the cerebrovasculature 
and increases in reactive oxygen species may contribute to the decline in cerebral blood flow.  
Aging brings about several alterations in the cerebrovasculature. Vessels in both cerebral 
gray and white matter undergo structural changes with increased tortuosity of vessels, significant 
rarefaction of arterioles, pericyte and capillary degeneration, loss of endothelium and thickening 
of the basement membrane [2, 26]. These vascular changes could have detrimental effects on the 
affected regions [2]. For example, with increasing vascular tortuosity, CBF becomes perfusion-
dependent  in the deep white matter regions, leaving this area susceptible to chronic 
hypoperfusion (inadequate blood flow) [27].  
Additionally, reactive oxygen species (ROS) are known to increase with age. ROS are 
thought to decrease NO bioavailability (resulting in endothelial dysfunction), and this reduction 
is associated with a decline in basal cerebral perfusion [28]. Moreover, ROS promotes vascular 
inflammation of the cerebral blood vessels [29, 30]. This could further increase ROS, leading to 
increased blood-brain barrier permeability to proinflammatory cytokines, vascular damage, and 
further reduced blood flow [8].  
Another alteration in cerebrovascular hemodynamics that occurs with age is an increase 
in cerebral pulsatile blood flow [23]. Pulsatile flow is characterized by blood flow with large 
fluctuations between systole and diastole that can be harmful to arteries. The primary mechanism 
thought to result in such flow in the brain is arterial stiffness and these relationships are a focus 
of the proposed research and are discussed in detail below (Section 2.3). 
These age-related declines in CBF emphasize the need for interventions to attenuate such 
cerebrovascular alterations as these can lead to cerebrovascular disease.    
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2.1.3 Cerebrovascular disease  
Cerebrovascular disease refers to any disorder that affects the supply of blood flow to the brain 
and can occur in both large and small arteries (microcirculation). Common cerebrovascular 
diseases include stroke, transient ischemic attack, small vessel disease, and dementia. 
Cerebrovascular disease risk factors (e.g. hypertension, diabetes, hypocholesteremia) exacerbate 
aging effects and can lead to serious cerebral damage and disease. Specifically, cerebrovascular 
disease risk factors alter vascular structure by promoting stiff, narrow, thick and tortuous vessels 
[29]. These changes are related to pathological alterations in resting cerebral blood flow, 
perturbations in CBF regulation and increases in cerebral pulsatile blood flow [29]. Major 
pathways through which cerebrovascular disease risk factors exert their harmful effects are 
oxidative stress and vascular inflammation leading to reductions in NO bioavailability [31, 32]. 
This loss of vasoregulatory capability of endothelial NO results in vasoconstriction and 
diminished NO-dependent vascular responses, leading to an impaired regulation of 
microvascular flow [32]. In addition, ROS increases the permeability of the blood-brain barrier 
also contributing to microvascular disease [33]. 
Stroke is a major cerebrovascular disease where blood flow and oxygen supply are 
interrupted from neurons (ischemia). This occurs most commonly due to an occluded vessel 
(embolic) but can also result from a ruptured vessel (hemorrhage) [29]. If ischemia occurs for 
more than a few minutes, irreversible damage with subsequent cell death and permanent 
symptoms occur (infarction). Symptoms vary depending on the size, severity and location of the 
affected area(s). For example, a single stroke can result in dementia if it occurs in key cognition 
regions while multiple, less severe strokes in the same regions can result in more gradual 
cognitive decline [29]. Transient ischemic attacks (TIA), sometimes called brief “mini” or 
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“warning” strokes, last only a few minutes and resolve before the ischemic tissue damage 
becomes irreversible [34]. Though TIAs have a short duration, they increase the likelihood of 
more severe future strokes.  
Small vessel disease is a group of pathological processes that affect the cerebral small 
arteries, arterioles, venules and capillaries and it is also referred to as microvascular disease [11]. 
One such disorder results in small (lacunar) strokes in the small vessels deep within the brain. In 
addition to lacunar strokes, microvascular diseases also include white matter lesions (seen as 
white matter hyperintensities on MRI) and microbleeds [11]. Microvascular disease is thought to 
be the most common neuropathology and plays a major role in stroke, vascular dementia and 
Alzheimer’s disease [33]. Furthermore, it is the leading cause of cognitive decline and functional 
loss in the elderly [11]. Of note, cerebral pulsatile blood flow is heavily implicated in 
microvascular disease. Since microvascular disease is thought to commonly underlie other 
cerebrovascular disorders, targeting cerebral pulsatile blood flow could be an important means 
by which to prevent cerebrovascular disease. 
Dementia is a clinical syndrome characterized by gradual cognitive decline and loss of 
function and independence [35] . Alzheimer’s disease, the most prevalent type of dementia, is a 
devastating neurodegenerative disease in which a progressive deterioration of brain structure and 
function occurs particularly in cognition [36]. Two main neuropathological features of 
Alzheimer’s disease are deposition of amyloid-β plaques and tau tangles. Amyloid-β 
accumulates in the presence of impaired waste clearance capabilities of the blood brain barrier, 
emphasizing the importance of the integrity of the blood brain barrier [1]. Furthermore, 
endothelial dysfunction, arterial stiffness, hypoxia and a decline in CBF have been implicated in 
the pathophysiology leading to Alzheimer’s disease [37].  
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Another form of dementia is vascular dementia, which is a progressive decline in 
cognitive function thought to be caused by chronic cerebral hypoperfusion (inadequate blood 
flow) and ischemia. Inadequate blood flow results in impairments of protein synthesis, synaptic 
activity, and glutamate excitocity, thereby affecting neuronal function and potentially leading to 
neuronal apoptosis [38, 39]. Though the etiology of vascular dementia and Alzheimer’s disease 
are thought to be different, vascular risk factors and dysfunction are heavily implicated in both 
[37]. 
These disorders highlight the importance of the health of the cerebral vasculature and of 
the cardiovascular system supplying the blood for normal cerebral function. Specifically, 
maintaining continuous CBF and protecting the brain from potential damage that could result 
from physiological insults such as toxic molecules and pulsatile blood flow.  
2.1.4 Cerebrovascular imaging methods 
2.1.4.1 Transcranial Doppler ultrasonography 
Transcranial Doppler (TCD) is a non-invasive ultrasound that measures CBF velocity (CBFv), a 
validated measure of CBF[40]. CBFv is assessed by placing a small, low frequency transducer (2 
MHz) on the scalp over a specific acoustic window where bone is the thinnest [41].  Several 
locations can be insonated depending on which artery is being assessed. The most commonly 
insonated artery is the MCA [42]. The MCA velocity is accessed utilizing the transtemporal 
window by the tragus above the zygomatic arch [41, 43].  The Doppler probe emits high-
frequency sound waves that are reflected off moving red blood cells. These reflected waves are 
then detected by the transducer resulting in a frequency shift, with this shift being proportional to 
blood velocity [44, 45].  This frequency shift refers to the difference between emitted and 
 14 
reflected waves: if the red blood cells are moving toward the transducer, the sound waves are 
compressed and the frequency increases while the opposite happens when red blood cells are 
moving away from the transducer [45].   
From the spectral waveform display, peak systolic and end diastolic blood flow velocity 
are directly measured. Mean blood flow velocity is estimated by: 
 
These values are obtained over a cardiac cycle and are automatically derived from the spectral 
analyzers in TCD [45].  In addition to these values, the pulsatility index is also calculated as a 
function of the CBFv parameters as follows: 
 
Pulsatility index is a common measure to describe the shape of the waveform [45]. For example, 
fast upstrokes of flow velocity and short peak velocity latencies generally result in a higher 
pulsatility index. Moreover, a higher pulsatility index reflects an increased cerebrovascular 
stiffness [2].  
TCD allows for non-invasive dynamic monitoring of CBFv and vessel pulsatility with a 
high temporal resolution and over extended periods of time. It is also relatively inexpensive, 
repeatable, and portable [45, 46]. TCD is not without limitations, however, with the main 
limitation being that it is highly operator dependent [45]  and there is a steep learning curve. 
Further, 10-20% of individuals have inadequate acoustic windows and spatial resolution is low 
due to variations in thickness and porosity of the bone [45, 46]. In addition, CBFv is only 
proportional to CBF when the vessel size remains constant. In this way, TCD values are an 
 15 
indirect measure of flow [47]. One way to address this limitation, however, is by capturing a 
more comprehensive picture of cerebrovascular hemodynamics by also measuring the supplying 
artery, internal carotid artery. This allows for comparisons between flow velocities in MCA and 
the internal carotid artery.   
Despite limitations, TCD has several clinical applications and is widely utilized for 
monitoring CBF during or following critical conditions such as sickle cell disease vasospasms, 
stenosis, intracranial occlusions, thrombosis, traumatic brain injury, stroke, and brain death [42, 
44, 46].  It has also been used extensively in physiological research studies [5, 48]   
2.1.4.2 Other cerebrovascular imaging methods 
Like TCD, several other methods measure some proxy of cerebral blood flow. Some of the most 
widely used methods in physiological research are near infrared spectroscopy (NIRS), arterial 
spin labeling (ASL), and functional magnetic resonance imaging (fMRI). 
NIRS is a non-invasive method used to measure regional cerebral tissue oxygen 
saturation and thus oxygen extraction and consumption. NIRS utilizes the specific absorption of 
near-infrared light by oxygenated, deoxygenated, and total hemoglobin [49]. This method has 
been used to evaluate brain activation during cognitive tasks and to compare neural metabolism 
in different populations (inactive vs aerobically trained). NIRS has excellent temporal resolution, 
but a primary limitation that skull, adipose/muscle tissue and scalp blood flow may create noise 
in the signal [49]. NIRS, unlike TCD, is an assay of the more distal microvasculature.  
ASL is an MRI technique to measure tissue perfusion by using the magnetization of 
water in the blood [50]. A 180-degree radiofrequency inversion pulse is applied to modify the 
magnetization of blood water, thereby tagging it and measuring the delivery of blood. ASL has 
also been used to evaluate differences in cerebral perfusion, both in quantity and location, in 
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different populations. This method provides an absolute quantification of perfusion, however it is 
expensive and the temporal resolution is poor due to the long latency (4 seconds) required to 
acquire a tagged and control image [50].  
Another non-invasive MRI method which uses blood-oxygen dependent contrast imaging 
(BOLD) is fMRI. This method utilizes the contrast in the magnetic properties of oxygenated 
versus deoxygenated hemoglobin as a measurement of metabolism (neural activity) denoted by a 
change in BOLD from baseline [51]. fMRI is often used in cognitive research to evaluate 
differential neural activation in different populations (e.g., aging) or after an intervention (e.g., 
exercise).  fMRI provides a detailed view of the brain in different dimensions; however, it is 
expensive and the results can vary widely based on parameters chosen.  
2.2 ARTERIAL STIFFNESS 
2.2.1 Pathophysiology 
Arterial stiffness is a pathological process which results from changes in the structural and 
cellular elements of the vessel wall. The main alterations are a loss of the elastic properties and 
remodeling of the vessel wall via enlargement and wall thickening [52]. Such changes result in a 
‘hardened’ artery with a reduced capability to expand and recoil in response to changes in 
pressure and flow [53].  Traditional cardiovascular risk factors such as aging, hypertension, 
diabetes mellitus, and hyperlipidemia are thought to promote arterial stiffness through several 
mechanisms [54].  
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Aging and hypertension, for instance, are thought to increase arterial stiffness through 
their effects on collagen and elastin. Collagen and elastin are two scaffolding proteins that are 
crucial to the stability, resilience and compliance of the vascular wall. However, an imbalance of 
these proteins can have adverse vascular effects [54]. Aging results in an overproduction of 
collagen and reduction of elastin [55], while hypertension can result in replacement of elastin 
with collagen as a response to excess pressure being exerted on the vessel wall by blood. Both 
processes lead to increased arterial stiffness.  Furthermore, accumulation of advanced glycation 
end products (AGE) secondary to hyperglycemia can alter the physical properties of proteins and 
form cross-links between proteins such as collagen [56, 57].  This AGE-linked collagen is stiffer 
and can further contributes to the loss of elasticity in vessels. Aging also results in an increased 
calcium content in the arterial wall, which may contribute to arterial stiffness by reducing 
distensibility. In addition, metabolic dysfunction such as hyperinsulinemia and hyperlipidemia 
can cause endothelial dysfunction, exacerbating arterial stiffness due to the pivotal role the 
endothelium plays in vascular tone [52]. Also, hormones such as angiotensin II and aldosterone 
may lead to increased smooth muscle cell tone, hypertrophy of smooth muscle cells, and fibrosis, 
resulting in a loss of elasticity [52, 58]. Lastly, increases in sympathetic nerve activity can 
increase vascular smooth muscle cell tone and, subsequently, contribute to arterial stiffness [58] . 
Aortic stiffness causes an increased load on the heart, resulting in higher systolic arterial 
pressure, while the loss of elastic recoil reduces diastolic blood pressure. Together these effects 
combine to increase pulse pressure, which is considered a surrogate measure of arterial stiffness 
for this reason [58]. This increased load requires more energy for a given ejection flow [52].  
Chronic ejection into stiffer vessels leads to a loss of efficiency in cardiac ejection and reduced 
perfusion of the heart itself [52].  
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Arterial stiffness has been established by numerous longitudinal epidemiological studies 
as an independent predictor of cardiovascular morbidity and mortality [59]. This has been 
demonstrated after adjusting for classical cardiovascular risk factors, for example those in the 
Framingham Risk score, which suggests that arterial stiffness has an added predictive value for 
detecting early cardiovascular disease progression [59, 60]. Moreover, arterial stiffness can be 
measured non-invasively, thus making it an ideal subclinical measure of cardiovascular disease 
in clinical research and practice. Methods for measuring arterial stiffness are discussed below. 
2.2.2 Methods for assessing arterial stiffness 
2.2.2.1 Pulse wave velocity 
During systole, the left ventricle contracts to eject blood into the ascending aorta, acutely dilating 
the aortic wall and generating a pressure wave that travels along the arterial tree [61].  The 
velocity of this wave provides a measurement of arterial compliance since stiff arteries 
inherently have a reduced capacity to dilate [53]. The pulse wave is reflected back from the 
peripheral vessels mainly from branching points.  In elastic arteries, the pressure wave travels 
slowly and is reflected back during diastole. In more stiff arteries, the pulse travels faster and is 
reflected back prematurely. This reflection of the wave during systole results in an increased 
cardiac load [62]. 
Carotid-femoral pulse wave velocity (cfPWV) is the gold-standard non-invasive measure 
of central (aortic) arterial stiffness. The reliability and validity of cfPWV against direct invasive 
measures on central arterial stiffness have been well established [59, 63].  cfPWV is assessed by 
dividing the estimated aortic distances measured externally using a measuring tape by the 
difference in transit time of the pressure waves [62, 64, 65]. Piezoelectric sensors are placed 
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superficially over the carotid and femoral artery sites to capture the pressure waves. The foot of 
each wave is used as a reference point for the arrival of the pressure wave to each site and the 
difference in time between sites serves as the denominator for calculation of cfPWV [59].  
Mounting evidence has established cfPWV as an independent predictor of cardiovascular, 
stroke [66] and all-cause mortality [67, 68].  A recent meta-analysis of 17,635 participants, 
revealed that each 1 standard deviation increase in cfPWV, was associated with a 23% increase 
in the risk for CHD events, 30% for CVD events, 28% for stroke, 28% for CVD mortality and 
17% for all-cause mortality even after adjusted for traditional CVD risk factors [69] . 
PWV is measured peripherally at other superficial arterial sites such as the radial, 
brachial, posterior tibialis or dorsalis pedis arteries [59]. Though less studied, some evidence 
suggests that peripheral PWV is a comparable predictor of coronary heart disease and stroke 
compared to cfPWV [70]. Further, these smaller vessels may be more responsive to interventions 
and are thus often utilized in clinical research.  
2.2.2.2 Pulse pressure 
As described earlier, pulse pressure is another measure of arterial stiffness and is calculated as 
the difference in systolic and diastolic blood pressure. Pulse pressure depends on left ventricular 
ejection fraction and the properties of the arterial wall, and therefore increases with higher stroke 
volume or increases in arterial stiffness [71]. In healthy compliant arteries, each cardiac 
contraction by the left ventricle ejects blood into the central arteries which is “accommodated” 
by stretching of the vessel walls in systole. An elastic recoil follows in late systole and diastole 
[72].  Pulse pressure is widened when arterial stiffness increases, particularly that of the aorta, 
due to the inherent reduced capacity of the arterial wall to expand and recoil to in response to 
increases in volume or pressure [71].  
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Like PWV, pulse pressure is an independent predictor of cardiovascular outcomes [73] 
and total mortality [74]. Some studies even suggest that pulse pressure better predicts outcomes 
as compared to other blood pressure parameters such as systolic, diastolic or mean arterial 
pressure [71, 75, 76]. Of note, in a study of over 19,000 men with low cardiovascular risk, a wide 
pulse pressure was found to be a significant predictor of all-cause and cardiovascular mortality 
over a mean follow-up of 19.5 years [77]. Similarly, in 1,243 chronic hemodialysis patients, 
every 10 mmHg increase in pulse pressure was associated with a 12% increase in the hazard of 
mortality over a nine year follow-up [78].    
2.2.2.3 Other methods for assessing arterial stiffness 
Common alternative methods to measuring arterial stiffness are ultrasound and pulse wave 
analysis.  Ultrasound is used to measure distensibility and compliance of large and accessible 
arteries. Thus, it is mainly used on the brachial, carotid, femoral, and abdominal aorta arteries. 
Ultrasound captures several images of the vessel wall per cardiac cycle. Vessel wall tracking 
edge-detection software calculates the minimum and maximum wall vessel areas [79]. 
Ultrasound of the common carotid artery is the most widely used. First a B-mode (2D) 
ultrasonography is captured parallel to the carotid, after which m-mode (moving) is placed 
perpendicular to the vessel, and a number cardiac cycles are recorded [80]. The primary 
limitation for the use of ultrasound to measure arterial stiffness is its limited resolution, which 
can lead to difficulty in detecting small changes in vessel diameter [79]. Additionally, it is 
technician dependent and only moderately repeatable [79]. 
Another method is pulse wave analysis which can be performed utilizing applanation 
tonometry (the same method used to measure PWV) or echo tracking. Pulse wave analysis 
provides indices of wave reflection such as augmentation pressure (the difference between the 
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first and second systolic peaks of a pressure waveform) and augmentation index (the quotient of 
augmentation pressure on pulse pressure expressed as a percentage) [54]. Of note, pulse wave 
analysis is complementary to PWV rather than interchangeable [59]. 
2.3 RELATIONSHIP BETWEEN ARTERIAL STIFFNESS AND 
CEREBROVASCULAR HEALTH 
2.3.1 Associations between arterial stiffness and cerebrovascular health 
Accumulating evidence suggests that central and peripheral arterial stiffness is associated with 
deleterious consequences in the brain. Increased arterial stiffness has been shown to be related to 
decreased CBF[81] and an increased risk of transient ischemic attacks [82], cerebral small vessel 
disease [7, 83, 84], stroke [66], deterioration of white matter neuronal fiber integrity [85], 
impaired cerebrovascular reactivity [86, 87], cognitive decline [88], vascular dementia,  cortical 
brain atrophy, and Alzheimer’s disease [89]. For example, in 692 older adults (mean age 63) 
with no history of stroke, transient ischemic attack or signs of neurological disease, those in the 
highest quartile of pulse pressure (> 54mmHg) had 2.55 (95% confidence interval of 1.03-6.30) 
times the odds of  advanced white matter lesions [90]. Higher odds of white matter lesions have 
also been reported with increased PWV [91].  Thus, arterial stiffness is related to reduced 
cerebral function and cerebrovascular health. 
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2.3.2 Arterial stiffness and cerebral pulsatile blood flow 
MCA blood flow is known to be more pulsatile in the presence of arterial stiffness.  One study 
measured arterial stiffness by brachial and central pulse pressure, cfPWV, and brachial-ankle 
(peripheral) PWV, and MCA pulsatility using TCD in 334 adults. MCA pulsatility index 
significantly increased with all indices of arterial stiffness even after adjusting for age, sex, 
smoking, alcohol intake, and 24-hour heart rate and mean arterial pressure (Table 1) [5]. 
Similarly, central and peripheral pulse pressure were found to be significantly associated with 
higher MCA pulsatile flow in 160 healthy adults (P<0.05) [4]. 
 
Table 1. Cross-sectional Correlations between Arterial Stiffness and Middle Cerebral Artery 
Pulsatile Flow [5] 
 
Arterial Stiffness Measure   n     r  P-value 
Carotid-femoral PWV             334           0.12  0.036 
Brachial-ankle PWV   334  0.23  <0.001   
Brachial Pulse Pressure  334  0.49  <0.001 
Central Pulse Pressure             334  0.34  <0.001 
24-Hour Pulse Pressure  334  0.44  <0.001 
 
The mechanism through which arterial stiffness is thought to increase pulsatile blood 
flow is through impaired Windkessel function [92]. Healthy elastic arteries expand and recoil to 
cushion the pulsatile blood flow generated by the left ventricle of the heart and allow for 
relatively non-pulsatile blood flow to reach the peripheral organs (e.g., the brain). With 
increasing age or the presence of cardiovascular risk factors, central arteries stiffen and are less 
capable of cushioning pulsatile flow [61]. This results in increased pulsations and pressure 
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gradients in central arteries, which in turn exposes the delicate, more distal microvasculature of 
the brain to the same harmful flow patterns. Due to the brain’s high demand for blood flow and 
its low vascular resistance, cerebral arteries can be damaged when exposed to high pulsatile flow 
that has not been cushioned by the supplying arteries [3].  
Pulsatile flow accelerates the alterations in cerebral hemodynamics known to occur with 
age, such as reduced cerebral blood flow.  In fact, high pulsatile pressure and flow can tear 
smooth muscle cells and endothelial cells off the vessel wall, resulting in hemorrhage or 
thrombosis in small arteries, arterioles and capillaries [61].  Age-related weakening of the arterial 
walls in concert with this pulsatile stress can further induce thrombosis, lacunar infarction, 
endothelial damage, fluid “exudation”, microbleeds and microaneurysms [61, 93]. These events 
can lead to more serious cerebral disease, for example, microbleeds can cause a buildup of 
amyloid plaques [94], which are a hallmark of Alzheimer’s disease [95].   
In summary, cerebral pulsatile flow can lead to cerebrovascular pathology that may result 
in deleterious consequences such as white matter lesions [96, 97]  and Alzheimer’s disease [12].  
Due to these serious consequences of cerebral pulsatile blood flow, it is crucial to better 
understand the mechanisms and effective prevention or treatment methods. We hypothesized that 
reducing arterial stiffness through physical activity could result in reduced pulsatile blood flow. 
However, as will be discussed in the following section, limited research has investigated 
relationships between physical activity, arterial stiffness and cerebrovascular hemodynamics. 
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2.4 BENEFITS OF PHYSICAL ACTIVITY 
2.4.1 General health benefits   
It is well established that physical activity is effective in the primary and secondary prevention of 
a variety of chronic diseases such as cardiovascular disease, diabetes mellitus, cancer, 
hypertension, obesity, mental illness (anxiety, depression, schizophrenia), sleep apnea (and other 
sleep disturbances), osteoporosis and premature mortality  [16, 98-101].  The American College 
of Sports Medicine recommends participating in moderate-intensity aerobic physical activity for 
30 minutes per day on most days of the week, in bouts of at least 10 continuous minutes, for a 
total of 150 minutes per week [15].  Due to the fact that individuals may be more likely to adhere 
to intermittent bouts of 10 minutes rather than a 30-minute continuous bout [102], studies have 
been conducted evaluating whether these intermittent bouts have the same health benefits as 
continuous 30-minute bouts of equal overall volume. Exercise intervention studies have found 
that exercise prescriptions of three 10-minute bouts accumulated throughout the day are as 
effective as one 30-minute bout per day for improving cardiovascular risk factors such as 
cardiorespiratory fitness, blood pressure, lipid metabolism and cholesterol levels [102-106]. It is 
unknown, however, whether 10-minute bouts have acute or long-term benefits to arterial 
stiffness, pulse pressure or cerebrovascular hemodynamics. 
2.4.2 Cerebrovascular health benefits  
Exercise leads to both structural and functional changes in the brain such as increases in grey 
(neurogenesis) and white matter (myelinated axons) volume [107], as well as improvements in 
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white matter integrity.  A specific cerebrovascular benefit is increased basal CBF (perfusion), 
which is thought to occur through both acute and chronic effects of exercise. Acute effects 
include NO bioavailability and antioxidant activity, while chronic adaptations include 
angiogenesis and attenuation of tortuous vessels.  
One mechanism through which exercise may acutely increases CBF is increased NO 
bioavailability. NO is known to enhance endothelial function by regulating vessel tone at rest 
and during activation [3], which is key to the regulation of cerebral blood flow. Increases in 
vascular sheer stress may upregulate endothelial NO synthase expression, leading to increased 
NO bioavailability and  NO-dependent vasodilation [108]. In addition to sheer stress, NO 
bioavailability is preserved through exercise-related decreases in ROS, which are known to have 
deleterious effects on NO bioavailability. Exercise is associated with increased antioxidant 
activity and decreased oxidative stress, and thus exercise can attenuate the negative effects ROS 
has on NO bioavailability [8]. This NO-mediated enhancement of endothelial function may 
facilitate improved neurovascular coupling and, consequently, cerebrovascular health [37]. 
  Chronic adaptations to increased CBF due to exercise are thought to result from collateral 
blood vessel recruitment and angiogenesis [8, 109].  Per the vascular niche hypothesis, 
neurogenesis cannot occur without corresponding angiogenesis to support its metabolism [109-
111]. Both neurogenesis and angiogenesis result from insulin-like growth factor 1, brain-derived 
neurotropic factor, vascular endothelial growth factor and bone marrow-derived endothelial 
progenitor and CD34+ cells , all which are known to increase with exercise [8, 109]. 
  Another chronic adaptation through which exercise may improve cerebrovascular health 
is through an attenuation of tortuous vessels [112].  Tortuosity increases the length of the vessel, 
and there is a loss of kinetic energy with each ‘turn and loop.’ Consequently, more tortuous 
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vessels require an increase in blood pressure to maintain adequate blood flow [27]. 
Cerebrovascular tortuosity is known to increase with age, hypertension and disease [113, 114]. 
Yet, vessel tortuosity has been found to be attenuated in individuals who engage in physical 
activity [112].  
 Though much less studied, and thus the focus of the proposed study, exercise may also 
have a beneficial effect on cerebral pulsatile flow. One small intervention study (n=16) found 
that decreases in cerebral pulsatile flow were associated with increases arterial compliance (the 
inverse of arterial stiffness) post-intervention, [6]. Though cerebral pulsatile flow did not change 
significantly, potentially secondary to small sample and limited power, this preliminary 
association between arterial stiffness and cerebral pulsatile flow supports our hypotheses and 
warrants further research. 
These beneficial effects on cerebrovascular hemodynamics are thought to result in an 
improved regulation of CBF through endothelial function via NO, increased collateral flow, and 
healthier less tortuous vessels, all of which improve the ability of the cerebral vessels to meet the 
metabolic needs to neurons (neurovascular coupling). Improved neurovascular coupling and 
overall cerebrovascular health can attenuate the effects of aging and progression of the 
cerebrovascular disorders discussed in the previous sections, highlighting the importance of 
exercise. Evidence that exercise improves CBF includes observational and intervention studies 
discussed below. The effects of a single bout of exercise on cerebrovascular hemodynamics are 
less clear, and these were evaluated in this study. 
2.4.2.1  Observational studies 
Cross-sectional studies find that physical activity and cardiorespiratory fitness are positively 
associated with greater cerebral blood flow. In healthy men ages 18-79 (n=153 inactive, n=154 
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endurance trained), blood flow velocity in the middle cerebral artery (MCA CBFv) (a surrogate 
measure of cerebral blood flow) was consistently elevated by 9.1 ± 3.3 cm s -1 (17% higher) in 
those who participated in frequent vigorous aerobic training (>4 times per week over the 
previous two years), compared to their inactive counterparts [115]. Of note, this resulted in a 10-
year reduction of estimated cerebrovascular hemodynamic ‘age’. In the same study, age-related 
reductions in CBF were attenuated in the endurance trained men. Another study in 81 healthy 
males reported a positive linear relationship between VO2max and MCA CBFv (r=.58-.59, 
P<0.05) and similar attenuations in age-related declines in MCA CBFv with higher 
cardiorespiratory fitness (P<0.001). Like in the previous study, exercise-trained participants had 
an 11-year younger cerebrovascular hemodynamic ‘age’ versus the inactive participants. These 
participants were stratified into 1 of 4 groups based on their age (young ≤30 years vs old ≥ 60 
years) and lifetime physical activity (achieving ≥ 150 minutes per week of aerobic physical 
activity sustained during adult lifespan vs. not). MCA CBFv was highest in young active (64±13 
cm/s), followed by young inactive (52±11 cm/s), old active (46±11 cm/s) and old inactive (37±8 
cm/s) [116].  Yet another study found that more frequent physical activity and greater 
cardiorespiratory fitness was associated with better regulation of CBF in young healthy adults 
(n=55) [117]. 
Similar results have been observed using other neuroimaging methods such as NIRS and 
ASL. Higher fit women, regardless of age, were found to have improved cerebrovascular health 
as measured by greater regional cerebral oxygenation (NIRS) [118]. Similarly, endurance-trained 
middle aged adults were found to have greater regional cerebral perfusion (via ASL) compared 
to their inactive counterparts [119]. 
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These studies demonstrate improved cerebrovascular health in individuals who have 
higher cardiorespiratory fitness and greater physical activity levels. These benefits to subclinical 
cerebrovascular health measures are thought to explain observed relationships between physical 
activity and reduced risks of cerebrovascular disorders such as stroke and Alzheimer’s disease.   
2.4.2.2 Intervention studies 
Intervention studies have confirmed the relationships between physical activity and MCA CBFv 
found in cross-sectional studies. Twenty inactive, healthy, postmenopausal women (mean age 60 
years) were assigned to either an 8-week aerobic exercise intervention or a control group. The 
exercise group participated in mostly supervised aerobic exercise on 3-6 days per week, 
beginning with 30 minutes per day at 60% age-predicted maximum heart rate and progressing to 
40-60 minutes per day at 70-75% age-predicted maximum heart rate. The average frequency and 
duration were approximately 4 days per week with each exercise bout lasting approximately 47 
minutes. The control group was instructed to continue with their usual level of physical activity. 
The women in the intervention group showed significant increases in peak systolic, mean 
systolic and diastolic MCA CBFv as well as a significant decrease in cerebrovascular resistance 
(calculated as mean blood pressure divided by mean MCA CBFv). Further, though pulsatility 
index did not change significantly, changes in the pulsatility index were associated with changes 
in carotid artery compliance (a measure of arterial stiffness) [48].  
Similarly, in inactive young and older healthy adults, a mostly supervised 12-week 
aerobic exercise training intervention began with 20-30 minute sessions, 3 times per week, at 
65% heart rate range, and progressed to 40-50 minute sessions, 4 times per week, at 65-80% 
heart rate range.  This intervention resulted in an increased resting MCA CBFv and improved 
cerebrovascular autoregulation [120].   
 29 
Improvements in cerebrovascular hemodynamics and cerebrovascular function with 
exercise training are not limited to healthy individuals. For example, a 6-month aerobic exercise 
training intervention in hemiparetic stroke survivors (mean age of 60) was found to significantly 
improve ipsilesional and contralesional cerebrovascular autoregulation [121]. Due to the 
applicability of exercise in different populations for improvements in cerebrovascular health, it is 
important to understand the chronic and acute effects to develop population and disease 
appropriate interventions. Single bouts of exercise are an important starting point for 
understanding acute mechanisms and how, over time, these effects could lead to chronic 
adaptions. The limited research regarding the acute effects of a single bout of exercise on 
cerebrovascular hemodynamics is discussed below.  
2.4.2.3 Single bout of exercise  
Few studies have evaluated the acute effects of exercise on cerebral blood flow. Using ASL, 
global CBF[122] has been reported to increase acutely following exercise. However, regional 
decreases and increases have also been reported using other methods such as single-photon 
emission computed tomography and ASL [123-126]. Furthermore, studies using TCD have 
found inconsistent changes in MCA CBFv following a single bout of exercise. In one study, a 
40-minute bout at 60% of VO2max did not change MCA CBFv at 10, 30, or 60 minutes post-
exercise. It should be noted, however, that participants in this study were injected with sodium 
nitroprusside (a vasodilator) to induce hypotension and this could have affected the results [127]. 
In another study, 11 participants performed two identical high intensity cycling sessions of 30 
minutes on separate occasions. Following one of the exercise sessions (n=11), there was a 
significant 7% decrease in MCA CBFv at 6 minutes post-exercise. Following the other session 
(n=7), a nonsignificant 3% decrease in MCA CBFv was observed [128]. Yet another study 
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measured supine MCA CBFv pre- and post-marathon (within 4 hours of completion) and found 
no significant differences [129]. These inconsistencies may be due to limited sample sizes, 
differences in measurement methodology and timing, as well as variable exercise intensities.  
Also, these experimental studies have focused on mostly young, healthy individuals who are 
likely to have healthy CBF and these results may reflect a ceiling effect.   
In addition to the limited research on CBF acutely post-exercise, the acute effects of a 
single bout of exercise on cerebrovascular pulsatility have not previously been examined. Thus, 
we aimed to evaluate the effects of a single bout of exercise on cerebral hemodynamics, 
specifically CBF and pulsatile flow. Additionally, we focused on healthy, middle-aged adults as 
they are at a higher risk for subclinical cerebrovascular alterations and may be more likely to 
improve from a single bout of aerobic exercise.  
2.4.3 Effects on arterial stiffness 
It has been well established that aerobic exercise elicits beneficial cardiac and vascular effects 
[130]. Exercise-induced benefits on arterial stiffness occur acutely as well as chronically. Similar 
to acute mechanisms of cerebrovascular benefit described earlier, increased vascular sheer stress 
results in increased NO bioavailability as well as other vasodilators. NO is a potent vasodilator 
and reduces the vascular smooth muscle cell tone, thereby decreasing arterial stiffness[61]. 
Vasodilation of vascular muscle cells transfers stress from collagen fibers to elastin proteins 
[131]. In addition, the increased arterial pressure and heart rate from exercise may result in 
physical forces deforming the large blood vessels, thereby reversing and inducing chronic 
improvements in arterial stiffness such as connective tissue linking [132]. Furthermore, arterial 
baroreflexes may play a role in augmenting the vagal tone of the heart [132]. Lastly, afferent 
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nerves in the aortic arch and carotid artery send signals to the brain stem when distension occurs 
in these arteries during systole, resulting in inhibition of sympathetic outflow [132]. Repeated 
bouts of exercise induce larger vessel diameter and better endothelial function [133, 134]. 
Moreover, habitual exercise results in increased antioxidant activity and enhanced resistance to 
oxidative stress, all which can increase NO bioavailability [135]. These acute and chronic 
benefits on arterial stiffness due to exercise are supported by both cross-sectional and 
intervention studies. Less research has been conducted on the acute effects of a single bout of 
exercise on arterial stiffness. This evidence is discussed below. 
2.4.3.1  Observational studies  
Cross-sectional studies have established inverse relationships between arterial stiffness and 
physical activity or cardiorespiratory fitness. For example, central and peripheral arterial 
stiffness were greater in 405 young adults with poorer cardiorespiratory fitness [136]. After 
adjusting for age, gender, mean arterial pressure, anthropometrics, physical activity and other 
health behaviors, higher VO2max remained significantly associated with lower central (β= -0.18, 
P=0.008) and peripheral arterial stiffness (β= -0.20, P=0.002). Similar inverse relationships 
between cardiorespiratory fitness or physical activity and arterial stiffness  have been reported in 
children [137], adolescents [138], middle-aged adults and older adults [139, 140]. 
2.4.3.2 Longitudinal studies 
Aerobic exercise is known to reduce arterial stiffness as measured by PWV with interventions 
ranging in duration from 4 weeks to 6 months.  These interventions include diverse populations 
and exercise prescriptions ranging from 30 to 60 minutes per session at 40-80% maximum 
aerobic capacity. They include healthy adults [13, 141] and individuals with diabetes [142, 143], 
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pre-and stage-1 hypertension [143, 144], hypercholesterolemia [143] and metabolic syndrome 
[141]. Shorter studies have found that exercise can decrease arterial stiffness in as little as 24 
hours [145] to 6 days [146]. 
Extensive research has been conducted on the effects of exercise on blood pressure 
reductions (on average by 2-5 mmHg systolic and 1-4 mmHg diastolic blood pressure) [147], 
though fewer studies have investigated effects on pulse pressure. Reductions in blood pressure 
are not necessarily mirrored in pulse pressure, however systolic blood pressure has been shown 
to explains most of the pulse pressure variance [148].  Preliminary evidence suggests that pulse 
pressure is reduced with exercise training. For example, one study using pulse pressure as a 
primary target of exercise intervention found that an 8 weeks of 45-60 minutes at 60-79% of age-
predicted maximum heart rate significantly reduced pulse pressure [148] .  
2.4.3.3 Acute effects of a single bout of exercise 
A single bout of exercise has been shown to have acute effects on both central and peripheral 
PWV and pulse pressure. Twenty-three young, healthy men underwent a 60-minute bout of 
aerobic exercise at 65-75% of heart rate reserve. cfPWV as well as brachial and aortic pulse 
pressure were significantly reduced at 20- and 50-minute post-exercise (Table 2) (P<0.05) [149]. 
Similarly, central and peripheral PWV significantly decreased 20 minutes (P<0.05) [18] and 30 
minutes (P= 0.01-0.04) [17] following a 30-minute bout of aerobic exercise at 65% peak 
VO2max in moderately active as well as inactive young adults. In contrast, several studies have 
not found PWV to change following aerobic exercise [150-154]. There is evidence to suggest 
that three accumulated bouts of 10 minutes throughout the day can reduce blood pressure with 
chronic training, however, whether a single 10-minute bout has acute effects on blood pressure 
has yet to be evaluated. Furthermore, the acute effects of a 10- vs. 30-minute bout of exercise are 
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unknown on arterial stiffness, and thus we aimed to study these and examine whether these elicit 
benefits in dose-response manner.  
 
 
Table 2. Reductions in Arterial Stiffness 20 and 50 Minutes Following an Acute Exercise Bout 
[149] 
 
Arterial Stiffness Measure      Baseline    20 minutes     50 minutes 
Carotid-femoral Pulse Wave Velocity (m/s)    7.1±2.7 6.9±1.5 6.8±1.2  
Brachial Pulse Pressure (mmHg)     51.0±6.0     48.0±5.0          49.0±7.0 
Central Pulse Pressure (mmHg)     31.0±4.0      28.0±3.0         28.0±4.0 
 
2.4.4 Relationship between exercise-induced improvements in systemic and 
cerebrovascular hemodynamics  
The cardiovascular benefits of aerobic exercise, particularly those on arterial stiffness, are 
thought to enhance Windkessel function (the ability of vessels to recoil and expand and buffer 
pulsatile flow). This may improve cerebrovascular hemodynamics by attenuating the pulsatile 
flow reaching the brain [3, 131] and, consequently, reduce the risk for the cerebrovascular 
disorders thought to originate from pulsatile flow.  Furthermore, exercise may attenuate the 
reductions in CBF believed to occur as a result of systemic pulsatile flow [81] and could 
potentially lower the risk for the cerebrovascular disorders (e.g. stroke and vascular dementia). 
Preliminary research supports this mechanism, though the limited understanding motivated this 
project.  
 34 
2.4.4.1 Cross-sectional studies 
Though few studies have been conducted, it appears arterial stiffness is associated with cerebral 
hemodynamics. Associations between CBF and arterial stiffness were evaluated in master 
athletes and inactive middle-aged adults. Master athletes were individuals participating in 
moderate-to-vigorous aerobic exercise for 7.5 hours per week while inactive individuals reported 
participating in exercise less than once a week for the past year.  Master athletes had lower 
arterial stiffness and greater regional blood blow (measured by ASL) compared to their inactive 
counterparts [119]. However, no differences in brachial or central pulse pressure were found 
across groups and the relationship between pulse pressure and cerebrovascular hemodynamics 
were not evaluated. 
2.4.4.2 Intervention 
Our hypotheses are also supported by an exercise training study. A 16-week endurance training 
intervention was implemented in young tennis players with all participants engaging in the 
intervention. All participants attended 60-90 minute sessions three times per week at 65-75% and 
90% heart rate reserve before their mandatory 2-hour tennis practice. The intervention 
progressed over three phases including long distance running and short interval training. 
Interestingly, cerebrovascular hemodynamics (blood flow and pulsatile flow) were unchanged.  
However, carotid compliance was found to increase post-training and larger increases in 
compliance were associated with improved cerebrovascular hemodynamics. Specifically, higher 
CBF and greater attenuations of pulsatile flow in the MCA. Brachial pulse pressure was 
unchanged and its relationship to cerebrovascular hemodynamics was not evaluated  [6].     
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2.4.4.3 Single bout of exercise 
To be best of our knowledge, there are no studies evaluating whether a single bout of exercise 
effects cerebrovascular hemodynamics through reductions in arterial stiffness and pulse pressure.  
Thus, evaluating this relationship was an aim of this study. 
2.5 GAPS IN THE LITERATURE 
There is limited research on the acute effects of a single bout of exercise on arterial stiffness and 
cerebrovascular hemodynamics. The effect of a 30-minute bout of exercise on cerebral 
hemodynamics is unclear and the effects of a 10-minute bout are unknown. Additionally, more 
research is needed regarding the benefits of exercise on cerebral pulsatile flow. 
 Preliminary evidence suggests that arterial stiffness is reduced acutely following a 30-
minute exercise bout; however, the effects of a 10-minute bout have not been studied. 
Furthermore, whether the acute effects of a single bout of exercise on arterial stiffness and 
cerebrovascular hemodynamics are related is unknown. The aims of the proposed study were to 
evaluate whether single bouts of exercise of different durations (10-minute and 30-minute bout) 
can elicit improvements in cerebrovascular hemodynamics and arterial stiffness. Additionally, 
this study examined whether reductions in arterial stiffness explain the improvements in 
cerebrovascular hemodynamics. 
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3.0  METHODS 
3.1 RECRUITMENT AND SCREENING PROCEDURES 
Subjects were recruited using flyers (Appendix A) which instructed interested individuals to 
contact the Physical Activity and Weight Management Research Center. To determine initial 
eligibility, trained staff provided a description of the study and, after verbal consent, proceeded 
to the phone screening (Appendix B). Questions determined initial eligibility based on 
demographic information, medical history, general physical health and ability to complete study 
procedures. In addition, interested participants completed a Physical Activity Readiness 
Questionnaire (PAR-Q) [155]  as part of the phone screening to confirm that they were able to 
exercise safely. If “yes” was answered to one or more of the PAR-Q questions, participants were 
ineligible to participate.  Those found to be initially eligible after the phone screen were asked to 
attend an orientation session led by the principal investigator.  
3.2 SUBJECTS 
Fifteen middle-aged adults (ages 35-59 years old) were recruited to participate in this study. 
Middle-aged adults were of interest due to their increased risk for arterial stiffness, which 
predicts subclinical cerebrovascular disease, cognitive decline, and increased risk of dementia 
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later in life [88, 156]. Exclusion and inclusion criteria (Table 3) were assessed by self-report 
during the phone screening (Appendix B) and the baseline visit. Blood pressure was measured at 
the baseline visit. There were no exclusion criteria regarding level of physical activity due to the 
lack of evidence to suggest that those that are more physically active will have differential 
cerebral hemodynamics in response to an exercise stimulus compared to those who are inactive.  
 
Table 3. Inclusion/Exclusion Eligibility Criteria 
Inclusion Criteria Exclusion Criteria 
• Middle-aged adults (ages 35-59 years old) 
• Ability to provide informed consent 
• Willingness to watch National 
Geographic content 
• Ability to attend all four lab visits 
• Able to complete exercise sessions safely 
• Resting systolic blood pressures < 140 
mmHg and diastolic < 90 mmHg 
• Resting systolic blood pressures 140-159 
mmHg and diastolic 90-99 mmHg with 
PCP medical clearance 
 
• Inability to complete exercise sessions for 
any reason  
• Presence or history of cardiovascular or 
cerebrovascular disorders 
• Currently taking medication to control 
heart rate or blood pressure 
• For women, those currently pregnant, 
trying to get pregnant, or planning on 




3.3 ASSESSMENT PROCEDURES 
Measurements at the baseline visit included blood pressure, height, weight, body mass index, 
PWV distances, arm circumference and waist circumference. Outcome measurements included 
blood pressure and heart rate, PWV, and cerebrovascular hemodynamics (via  
TCD). These measurements were assessed at the beginning of each experimental visit and at 30 
and 60 minutes following the experimental condition (Table 4). Vascular assessment time points 
were chosen to be comparable to several previous studies [150-154, 157].  
 







Resting Blood Pressure X X X 
TCD  X X X 
PWV (carotid-femoral, 
carotid-radial)  
X X X 
  
3.3.1 Body height, weight and body mass index 
Height and weight were measured at the baseline visit while the participant wore lightweight 
clothing and no shoes. Bodyweight was measured to the nearest 0.1 kg on a Tanita WB 110A 
digital scale, and height was measured using a wall-mounted stadiometer. Two measurements of 
each were made and, if measurements differed by ≥ 0.5 cm (height) or  ≥0.2 kg (weight), 
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additional measurements were made until two were within range. The average of measurements 
within range was used for data analyses. Body mass index was computed as kg/m2.  
3.3.2 Arm circumference 
To determine proper blood pressure cuff size (Table 5), a Gulick measuring tape was used. The 
arm circumference was measured at the midpoint between the acromion process and the 
olecranon process on the right arm while the subject was standing upright, shoulders relaxed and 
right arm hanging loosely. Two measurements were made to the nearest millimeter. A third 
measurement was made if the first two measurements differed by more than 1.0 cm. The average 
of the measurements within range was used to select the appropriate cuff.  
 
Table 5. Blood Pressure Cuff Sizes 
Arm Circumference Cuff Size 
17.0 to < 24.0 cm  Adult small 
24.0 to <33.0 cm Adult 
33.0 to <41.0 cm Large Adult 
 
3.3.3 Waist circumference 
Waist circumference was measured while the subject was standing using a Gulick measuring 
tape. The hip area was located at the right ilium [158] and a horizontal line was drawn just above 
the uppermost lateral border of the right ilium. Then, a vertical line was drawn to cross the 
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horizontal line at the midaxillary line. The measuring tape was placed around the trunk in a 
horizontal plane at the level of the drawn line. The tape was parallel to the floor and was snug 
but did not compress the skin. Two measurements were made at the end of a normal expiration 
and were recorded to the nearest millimeter. A third measurement was made if the first two 
measurements differed by more than 1.0 cm. The average of the measurements within range 
were used for data analyses.  
3.3.4 Level of physical activity 
Physical activity levels were measured using the Paffenbarger Exercise Habits Questionnaire 
[159] (Appendix C) which included questions regarding number of stairs climbed and 
participation in recreational sports. Total weekly exercise minutes were calculated from the 
Paffenbarger Exercise Habits Questionnaire by adding minutes spent walking briskly and 
minutes spent in sport, fitness or recreational activities per week. 
3.3.5 Fitness 
Fitness was estimated using the fitness calculator created by the K. G. Jebsen Center of Exercise 
in Medicine at the Norwegian University of Science and Technology [160]. This calculator 
estimates VO2max using gender, age, height, weight, resting heart rate, waist circumference, age-
predicted maximum heart rate and level of physical activity (Appendix D). This equation was 
found to explain 61% and 56% of variance in VO2peak with standard error of the estimate of 
5.70 and 5.14 ml/min/kg for men (n=2067) and women (n=2193), respectively [161].  It is 
recommended as an estimate of fitness by the American Heart Association [162].  
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3.3.6 Resting blood pressure and heart rate 
Brachial artery blood pressure was measured in duplicate by an automated blood pressure 
monitor (Omron HEM-705) after a 10-minute supine rest. Pulse pressure was calculated by 
subtracting diastolic blood pressure from systolic blood pressure. Pre-condition and post-exercise 
time course measures of blood pressure included two blood pressure measurements with a 1-
minute rest between measures. These were averaged. 
3.3.7 Heart rate 
Participants wore a heart rate monitor (Polar A1) continuously throughout each experimental 
visit. Heart rate is an important covariate of cerebrovascular hemodynamics when measured by 
TCD. Thus, heart rate was recorded every minute during TCD measurements. Heart rate was 
also monitored and recorded every minute during the workload estimation, the 10-minute and the 
30-minute exercise sessions.  Additionally, heart rate was monitored every 5 minutes while 
watching National Geographic during the seated session (Section 3.4.2.1) and the seated portion 
of the 10-minute exercise (Section 3.4.2.2) session.  
3.3.8 Carotid-femoral and carotid-radial distances 
Using a tape measure, aortic distance was estimated by subtracting the distance from the carotid 
artery site to the sternal notch from the distance of the sternal notch to the femoral artery site 
[65]. Carotid radial distance was estimated by measuring from the carotid artery site to the radial 
artery site with the arm in anatomical position [65].  
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3.3.9 Carotid-femoral and carotid-radial pulse wave velocity 
Central and peripheral arterial stiffness were measured with the subject in a supine position using 
tonometry and the Complior Analyse (Alam Medical). Sensors were placed on the right side of 
the body by the principal investigator (inter- and intra-technician ICCs for PWV were 90% and 
94-98%, respectively). Piezoelectric sensors were placed on the skin surface over the carotid and 
radial artery sites, and over thin fabric (e.g., cotton pants, spandex) on the femoral artery where 
the pulse was most strongly felt. Sensors were held in place until 10 valid waveforms were 
captured for each scan with low error, ideally ≤ 5% but up to 10% was accepted. Average 
carotid-radial and carotid-femoral PWV (m/s) were calculated as the distance divided by the 
average time differential between the foot of the waveform at the carotid and radial or femoral 
sites [59, 62, 64, 65].   Three scans were measured at each site and were averaged to reduce 
measurement error. 
3.3.10 Transcranial Doppler ultrasonography 
Cerebrovascular blood flow velocity of the MCA and extracranial internal carotid artery (ICA) 
was measured bilaterally for one minute using a 2 MHz noninvasive ultrasound probe (Terumo; 
Spencer Technologies) by the principal investigator (intra-rater reliability was 85-97% across 
TCD measures in 2016). Changes in cerebrovascular blood flow can be inferred from changes in 
blood flow velocity. To insonate the MCA, the probe was placed on the temporal bone window 
and readings at depths of 40-65 mm were made [41, 43]. The extracranial ICA was insonated at 
shallower depths of 35-50 mm using the submandibular approach (below jaw) [41]. The depth, 
location of probe, and bony landmarks were recorded so that the TCD recording position 
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remained the same in each subject and the same approach was used for each condition as well as 
between conditions. Quality of the measurements was rated from poor to excellent based on how 
well the envelope captured the waveforms, the strength of the signal, the direction and depth that 
is consistent with MCA flow. Any scan with a rating below adequate was not used. 
Cerebrovascular pulsatile flow was calculated as the difference between peak systolic and 
diastolic flow velocities divided by mean flow velocity.  
3.4 PARTICIPANT VISITS 
All enrolled participants attended four separate visits: one baseline visit and three 2.5-hour 
experimental visits.  Participants attended these visits between March 2017 and May 2017 at the 
Physical Activity and Weight Management Research Center. 
3.4.1 Orientation and baseline visit 
The principal investigator reviewed the study protocol with participants and answered any 
questions before participants provided informed consent. Height, weight, arm and waist 
circumference and distances from the carotid artery site to the radial and femoral artery sites 
were measured. Participants completed a Paffenbarger Exercise Habits Questionnaire to report 
their level of physical activity (Appendix C) [159].  
Participants were also familiarized with the treadmill and underwent a workload 
estimation (Appendix E) to establish their starting speed to reach their heart rate target zone (70-
75% of age-predicted maximum heart rate) during the exercise sessions. Age-predicted 
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maximum heart rate was calculated as 220 – age in years [163]. During the workload estimation, 
the treadmill speed and grade were adjusted based on heart rate response for the individual until 
the target heart rate of 70-75% of age-predicted maximum was attained.  For this session, the 
speed started at 2.4 mph and 0% grade (elevation).  Speed increased by 0.2 mph each minute 
until the target heart rate was attained or a walking speed of 3.4 mph was attained.  If the target 
heart rate was not achieved at a walking speed of 3.4 mph, the grade of the treadmill was 
increased by 0.5% each minute until the target heart rate was achieved. This target heart rate 
zone represents a moderate-to-vigorous intensity and was chosen for comparability to previous 
studies [145, 149]. 
3.4.2 Overview of experimental sessions 
All participants completed each experimental session (Figure 2) at separate visits in a 
randomized order (Section 3.4.3). Visits to the lab were at least 48 hours apart and no more than 
seven days apart. Additionally, each participant had the same appointment start time for each of 
their three experimental visits (Section 3.4.4). Upon arrival to each visit, adherence to 
instructions to abstain from moderate-to-vigorous physical activity for 24 hours, caffeine, and 
alcohol, nicotine for 12 hours, and a 4-hour fast was verbally confirmed and recorded. 
Participants were then instructed to put on a heart rate monitor which they wore for the duration 
of each experimental visit. Participants were prompted to use the restroom prior to and following 
each experimental visit. If a restroom break was necessary, it was recorded. At the end of each 
session, a bottle of water was provided to the participant for consumption ad libitum.  
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                      Figure 2. Overview of Experimental Sessions 
3.4.2.1 Seated session (SIT) 
Immediately following baseline assessments, participants were asked to sit and watch a 
preselected documentary series from the National Geographic Channel website for 30 minutes. 
National Geographic Channel was selected due to its options for neutral content which would be 
less likely to affect outcomes such as blood pressure and heart rate. Willingness to watch 
National Geographic content was determined during the phone screening (Appendix B). 
3.4.2.2  10-minute exercise bout (EX10) 
Immediately following baseline assessments, participants watched the same documentary series 
for 20 minutes, after which they began their 10-minute moderate-to-vigorous exercise bout. The 
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10-minute exercise bout started at the speed and grade established at the baseline visit (Section 
3.4.1). Thereafter, heart rate was monitored each minute, with speed or grade adjusted to 
maintain the target of 70-75% of age-predicted maximal heart rate. Speed and grade were 
adjusted based on each individual’s heart rate response using an algorithm developed by Dr. 
John Jakicic at the Physical Activity and Weight Management Research Center (Appendix F). 
Minutes 4 and 5 of the first 5-minute interval were averaged and the appropriate adjustment was 
made if this average heart rate was outside of the 70-75% heart rate zone.  For example, if the 
average heart rate for minutes 4-5 was below the 70-75% heart rate zone, speed was increased by 
0.2 mph. The participant then walked at this speed for minutes 6-10.  If speed was already at 3.4 
mph and heart rate was below the targeted range, then grade was adjusted by 0.5%. If heart rate 
was within the prescribed zone, no adjustments were made. All adjustments were recorded. 
3.4.2.3  30-minute exercise bout (EX30) 
Immediately following baseline assessments, participants walked on the treadmill for 30 
minutes.  The exercise session started at the speed and grade established at the baseline visit 
(Section 3.4.1) Thereafter, heart rate was monitored each minute, with speed or grade adjusted 
according to the procedures noted above for the 10-min exercise condition. These procedures 
were repeated at minutes 9-10, 14-15, 19-20, and 24-25 (Appendix G). All adjustments were 
recorded. 
3.4.3 Randomization and allocation procedures 
There were six possible orders. Using 1 as SIT, 2 as EX10 and 3 as EX30, potential orders of 
conditions are as follows: 123, 132, 213, 231, 312, 321. To achieve counterbalance of all orders, 
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two participants were randomly assigned to each of the six experimental orders (n=12) and the 
remaining three were randomly assigned an order.  
3.4.4 Standardization and timing 
The timing of the experimental visits was standardized such that they all took place between 
11:40am and 5:00pm and standardized within participant such that each participant had the exact 
same appointment start time for each of their three experimental conditions. This was based on 
previous research in our laboratory that suggests diurnal variation in cerebrovascular 
hemodynamics across the day [164]. In addition, protocol timing was tightly controlled and 
monitored (Appendix H). Timeframes were allotted for measuring each outcome (Table 6) and 
these times were adhered to. After each experimental condition, participants laid in a supine 
position until it was time to begin the post-condition measurements. To limit potential 
hemodynamic influences of postural changes, participants remained supine until the end of the 
last 60-minute post-session measurement. 
Table 6. Standardized Timing 
Baseline Measurement Transitions 30- and 60-minute Post-Session 
Supine Rest (10 min) 
Duplicate Blood Pressures (3 min) 
TCD (10 min) 
      Each MCA (3 min) 
      Each ICA (2 min) 
Supine PWV (5 min) 
From PWV to computer (3 min) 
From room to treadmill (2-5 
min) 
From treadmill to room (2-5 
min) 
 
Duplicate Blood Pressures (3 
min) 
TCD (10 min) 
      Each MCA (3 min) 
      Each ICA (2 min) 
Supine PWV (5 min) 
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3.4.5 Participant compensation 
Participants were compensated $100 for completing the 3 experimental sessions (SIT, EX10 and 
EX30), each on a separate visit. If a participant did not complete all sessions, they were paid $25 
for each session completed.  
3.5 STATISTICAL ANALYSES 
Paired t-tests or Wilcoxon signed-rank tests were performed, as appropriate, to evaluate 
differences in heart rates and parameters of experimental sessions. To evaluate specific aims I-
III, linear mixed models estimated effects for cerebrovascular hemodynamics (systolic, diastolic, 
mean and pulsatile blood flow), and arterial stiffness (pulse pressure and PWV) over the 1-hour 
trajectories and across conditions. Analyses investigated whether outcome measures differed by 
group, time point, or differ as a function of group and time point (i.e., interaction) and adjusted 
for order of condition, age, and gender. MCA and ICA CBFv were additionally adjusted for heart 
rate.   Overall linear effects of time were not evaluated due to variable non-linear effects over 
time. Rather, pairwise differences at each time points were evaluated if no group by time point 
interactions were observed. Pairwise differences at each time point were also analyzed (at 30-and 
60-minute post-session assessments) in linear mixed models restricted to the single post-session 
time point and adjusted for baseline value, order of condition, age, and gender. Linear mixed 
models were also used to assess differences in baseline values across conditions adjusted for 
order of condition, age and gender.  To evaluate Specific Aim IV, mixed linear regression 
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models evaluated whether changes in arterial stiffness were related to changes in cerebral 
pulsatile blood flow.    
3.6 POWER ANALYSIS 
Sample size was calculated using G*Power (Universität Düsseldorf).  Because this is the first 
study to evaluate whether an acute bout of exercise yields decreases in cerebrovascular pulsatile 
blood flow (measured by pulsatility index), we estimated sample size assuming 80% power, two-
sided α=0.05, a within-subjects correlation of 0.80 based on data from another randomized 
crossover study conducted in our laboratory[164] (r=0.80-0.95), and assuming a small between-
condition effect size (SIT, EX10, or EX30) of 0.25 (corresponding to η2 = 6%).  Given these 
assumptions, 12 subjects were required. Based on a 20% estimate of missing data (e.g., rare 
inability to insonate vessels), 15 subjects were recruited.
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4.0  RESULTS 
The purpose of this study was to evaluate acute effects of aerobic exercise on 1-hour trajectories 
of cerebrovascular hemodynamics and arterial stiffness across three conditions: sitting (SIT), 10-
minute exercise bout (EX10) and 30-minute exercise bout (EX30). This study used a randomized 
crossover design.  The results are presented below, starting with participants and experimental 
sessions, and following with results organized by specific aim. 
4.1 PARTICIPANTS  
4.1.1 Recruitment and enrollment 
Telephone screenings were conducted on a total of 27 interested individuals. Of these potential 
participants, five were ineligible due to an inability to participate in all study visits (n=3), being 
outside of age range (n=1) or reporting chest pain when not doing physical activity in the month 
prior (n=1). Of those eligible based on the phone screening, four were unable to be scheduled for 
the baseline visit due to scheduling conflicts (n=2) or nonresponsiveness (n=2). One participant 
became ineligible at the baseline visit due to resting blood pressure in the Stage II hypertensive 
range. One became ineligible due to resting blood pressure in the Stage I hypertensive range and 
unwillingness to obtain primary care physician (PCP) clearance to participate. Finally, one 
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                            Figure 3. CONSORT Diagram 
participant became ineligible after being randomized due to an inability to complete the exercise 
session during their first experimental visit (EX30). Figure 2 displays the CONSORT diagram.  
4.1.2 Participant characteristics 
Fifteen adults between the ages of 36-59 years completed all research procedures in this 
crossover study. Participants had a mean age of 45.4 (8.9) years, a mean BMI of 26.4 (4.2) kg/m2 
and were mostly non-Hispanic (73.3%), white (66.7%) women (87.0%).  Additionally, most 
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Table 7. Participant Characteristics 
                                                                            Mean (SD) or n, %                                       Range 
Age, years          45.4 (8.9)      36-59 
Height (cm)                       165.5 (10.2)                   149.1-184.9 
Weight (kg)                                     73.0 (18.4)      53.3-116.8 
Body Mass Index, kg/m2                                    26.4 (4.2)      21.5-34.5 
Waist Circumference (cm)                                   91.1 (12.6)      75.7-112.1 
Gender 
   Female                                     13, 87.0% 
   Male                                     2, 13% 
Ethnicity 
   Hispanic           4, 26.7% 
   Non-Hispanic          11, 73.3% 
Race 
   White or Caucasian         10, 66.7% 
    Black or African American        1, 6.7% 
    Asian                        3, 20.0% 
    Other                        1, 6.7% 
Education 
    High school                                1, 7.0% 
    College            8, 53.0% 
    Post graduate                                      6, 40.0% 
Occupational Status 
    Full-time          9, 60.0% 
    Part-time          1, 7.0% 
    Student                                     3, 20.0% 
    Homemaker          2, 13.0% 
Cardiorespiratory Fitness and Physical Activity 
    Estimated VO2max (ml/min·kg)                                   37.0 (5.3)     30.0-45.0 
    Duration of Workload Estimation (minutes)                 14.5 (8.6)                                              2.0-30.0 
    Weekly Exercise (minutes)                      201.0 (224.8)                                              0.0-765.0 
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participants worked full time (60.0%) and were educated with a college degree (53.0%) or a 
post-graduate  degree (40.0%). Demographic characteristics are reported in Table 7. Participants 
had a wide range of fitness and physical activity levels. The mean estimated VO2max was 37.0 
(5.3) ml/min·kg while the mean workload estimation duration was 14.5 (8.6) minutes. 
Participants reported climbing 13.2 (11.4) flights per day (range 2-45), walking briskly for at 
least 10 minutes in duration for the purpose of transportation or exercise for 113.3 (108.6) 
minutes per week (range 0-360) and participating in sports, fitness or recreational activities not 
including household or occupational activities for 87.6 (134.2) minutes per week (range 0-450). 
Combining minutes spent walking briskly and minutes spent in sport, fitness or recreational 
activities per week (Table 7), 46.7% of participants met American College of Sports Medicine 
physical activity guidelines of 150 minutes per week. 
4.2 WORKLOAD ESTIMATION 
During the baseline visit, participants completed a workload estimation (Appendix E) to 
establish their exercise sessions’ starting speed corresponding to their heart rate target zone (70-
75% of age-predicted maximum heart rate) (Section 3.4.1.). Across the workload estimation, the 
average speed was 3.3 (0.2) mph and the average grade was 4.4 (4.1) %. Average 70-75% of 
age-predicted maximum heart rate, speed, grade at termination and time to termination are 






Table 8. Exercise Parameters for the Workload Estimation 
                                                Mean (SD)            Range 
 
70% of Age-Predicted Max Heart Rate (bpm)        122.2 (6.0)         113.0-129.0 
75% of Age-Predicted Max Heart Rate (bpm)        131.2 (6.4)         121.0-138.0 
Average Termination Heart Rate (bpm)         124.3 (6.6)         114.0-134.0 
Percent APMHR of Average Termination HR (%)                71.2 (1.5)          69.8-75.1 
Average Termination Speed (mph)                     3.3 (0.2)          2.6-3.4 
Average Termination Grade (%)                     4.4 (4.1)           0.0-12.0 
Average Termination Time (minutes)                       14.5 (8.6)          2.0-30.0 
 
4.3 EXPERIMENTAL SESSIONS 
4.3.1 Comparison of sitting heart rates (SIT vs EX10)  
Immediately following baseline testing, participants watched a pre-selected neutral National 
Geographic series for 30 minutes in SIT and 20 minutes in EX10. Bathroom breaks were allowed 
if necessary; however, no bathroom breaks were taken while watching the series.  
Though participants watched the same National Geographic series in both SIT and EX10, 
average heart rate was compared to demonstrate comparability. A paired t-test revealed average 
heart rate during SIT was not different from average heart rate during the 20-minute sitting 




Table 9. Comparing Sitting Heart Rates (SIT vs EX10) 
         Mean (SD)              Range 
 
Average Heart Rate for SIT (bpm)       66.2 (11.3)                     44.3-89.6 
 
Average Heart Rate for the  
Sitting Portion of EX10 (bpm)                        67.2 (10.2)          53.4-90.6 
 
 
       Values are reported as Mean (SD). *P<0.05 compared to EX10.**P<0.01 compared to EX10. 
 
4.3.2 Comparison of exercise session parameters (EX10 vs EX30) 
Immediately following baseline testing, participants completed a 30-minute exercise bout in 
EX30. In EX10, participants completed a 10-minute exercise bout immediately following the 20-
minute sitting portion. These exercise sessions began at the predetermined speed from the 
workload estimation. Speed or grade were adjusted based on the average heart rate of the last 
two minutes of the each 5-minute interval (Appendices F and G). Table 10 displays average 
heart rate for each 5-minute interval and its corresponding percentage of age-predicted maximal 
heart rate for EX10 and EX30.  
Average heart rate during EX10 was 124 (7) beats per minute while the average percent 
of age-predicted maximum heart rate was 71%. Additionally, an average of 6 out of 10 minutes 
were within the target range (61% of the exercise bout)  and 1 minute was above the target range 
(14% of the exercise bout).  Average speed was 3.4 (0.2) mph and the average grade was 4.8 
(4.1) %. Average heart rate during EX30 was 128 (7) beats per minute while the average percent 
of age-predicted maximum heart rate was 73%. Additionally, an average of 13 out of 30 minutes 
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were within the target range (45% of the exercise bout) and 11 minutes above the target range 
(37% of the exercise bout).  Average speed was 3.4 (0.2) mph and the average grade was 4.7 
(4.2) %. These values are reported in Table 11. 
 
  
Table 10. Average Heart Rate and Age-Predicted Maximal Heart Rate Percentage Across 5-
Minute Intervals in EX10 and EX30    
 
           EX10                               EX30                 
                                       
                                                                    Mean (SD)       HR%     Mean (SD)           HR% 
 
Minutes 1-5 Average Heart Rate         120.9 (7.7)    69.3 (2.9)      118.9 (7.9)        68.1 (3.8)  
 
Minutes 6-10 Average Heart Rate         127.5 (8.3)    73.0 (2.4)      125.9 (8.7)        72.1 (3.6) 
  
Minutes 11-15 Average Heart Rate   ____        ____      128.9 (9.2)        73.8 (3.4) 
  
Minutes 16-20 Average Heart Rate   ____        ____      131.4 (8.7)         75.2 (2.7) 
  
Minutes 21-25 Average Heart Rate   ____        ____      132.5 (6.6)         75.9 (1.9) 
   
Minutes 26-30 Average Heart Rate   ____        ____      131.9 (6.4)         75.5 (1.5)  
Values are reported as Mean (SD). 
 
Though both the 10- and 30-minute exercise bouts in EX10 and EX30 had the same 
starting speed and grade, average heart rate, average corresponding percent of age-predicted 
maximum heart rate, speed, grade and minutes below, within and above range as well as their 
corresponding percentage were compared to determine if EX10 and the first 10 minutes of EX30 
were similar. Additionally, these parameters were compared between EX30 (overall) and EX10. 
Table 11 displays these values. 
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Table 11. Parameters of EX10 vs EX30 (First 10 Minutes and Overall) 
                                                                         EX10                 EX30               EX30 
                 (first 10 min)         (overall) 
 
Average Heart Rate (bpm)               124.2 (7.4)      122.4 (7.7)         128.3 (7.2)** 
   
Average Corresponding Percent of APMHR        71.1 (2.1) 70.1 (3.3)    73.5 (2.2) ** 
 
Average Minutes Below Range   2.5 (2.2) 4.5 (3.3)*    5.3 (4.6)* 
 
Average Minutes Within Range   6.1 (2.3) 4.2 (2.9)    13.4 (5.0)** 
 
Average Minutes Above Range   1.4 (1.7) 1.2 (2.5)    11.2 (7.2)** 
 
Average Percent of Minutes Below Range  25.3 (21.7) 44.7 (32.9)*    17.8 (15.4) 
 
Average Percent of Minutes Within Range           60.7 (22.5) 42.0 (28.8)    44.7 (16.7) 
 
Average Percent of Minutes Above Range             14.0 (17.2) 12.0 (25.1)    37.3 (24.0)* 
 
Average Speed (mph)    3.4 (0.2) 3.3 (0.2)    3.4 (0.1) 
 
Average Grade (%)      4.8 (4.1) 4.9 (4.2)    4.7 (4.2) 
______________________________________________________________________________ 
Values are reported as Mean (SD). *P<0.05 compared to EX10.**P<0.01 compared to EX10. 
 
Comparing the first 10 minutes of EX30 to EX10, average heart rate was not significantly 
different in EX10 compared to the first 10 minutes of EX30 (P=0.18). Similarly, neither average 
speed (P=0.32) nor grade (P=0.09) were significantly different during the first 10 minutes of 
EX30 and EX10. Average corresponding percent of age-predicted maximum heart rate was not 
significantly different (P=0.20). Average minutes below range was significantly higher in the 
first 10 minutes of EX30 compared to EX10 (P=0.03), while minutes within range approached 
significance (P=0.07) and above range were not different (P=0.77). Average percent of minutes 
below the target range was significantly higher in the first 10 minutes of EX30 compared to 
EX10 (P=0.03) while average percent of minutes within the target range approached significance 
(P=0.07) and average percent of minutes above the target range were not different (P=0.39). 
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Comparing the full 30 minutes of EX30 to EX10, average heart rate was significantly 
lower in EX10 compared to EX30 (P=0.001). Neither average speed (P=0.38) nor grade (P=0.79) 
were different. Average corresponding percent of age-predicted maximum heart rate was 
significantly higher in EX30 (P=0.001) compared to EX10.  However, it should be noted that the 
average percent of age-predicted heart rate maximum was within the targeted 70-75% range for 
both exercise sessions and only differed by 2% between conditions.  Average minutes below 
(P=0.02) within (P=0.0003) and above (P=0.001) the target range were significantly higher in 
EX30 compared to EX10; however, of note, there were more minutes in the 30-minute bout than 
there are in the 10-minute bout of exercise. Average percent of minutes below (P=0.10) the 
target range were not different, while average percent of minutes within the target range was 
approaching significance (P=0.06) and average percent of minutes above range were higher in 
EX30 compared to EX10 (P=0.001). 
4.4 ANALYSIS OF DATA BY SPECIFIC AIM 
Baseline values across conditions are presented first. Then, blood pressure and heart rate results 
are presented as they are important covariates. Following these, results are reported by specific 
aim.  
4.4.1 Baseline values across condition 
Most baseline values were similar across condition (P>0.05) except for MCA peak systolic and 
mean CBFv as well as heart rate. Baseline MCA peak systolic CBFv was significantly higher in 
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EX10 compared to SIT (β =4.22 cm/s, P=0.02) and EX30 (β =4.41 cm/s, P=0.02). Similarly 
baseline MCA mean CBFv was significantly higher in EX10 compared to SIT (β =3.04 cm/s, 
P=0.04) and EX30 (β =3.05 cm/s, P=0.04). Baseline heart rate was higher in EX10 compared to 
SIT (β =2.61 bpm, P=0.02). Table 12 reports individual baseline values in SIT, EX10 and EX30.  
To reduce the potential influence of baseline differences, all analyses evaluating pairwise 
differences at the 30- and 60-minute post session assessment in the following sections were 
adjusted for baseline values.  
Table 12. Comparison of Baseline Values Across Conditions 
                                                                     SIT                                   EX10                             EX30 
Systolic Blood Pressure (mmHg) 111.3 (11.2)   110.7 (8.0)  108.5 (7.7) 
Diastolic Blood Pressure (mmHg) 70.0 (6.9)   69.2 (7.2)  68.37 (7.9) 
Pulse Pressure (mmHg)  41.3 (6.7)   41.5 (4.8)  40.2 (4.8) 
Heart Rate (bpm)   59.6 (10.7)   62.2 (11.1)*              61.7 (10.4) 
MCA Cerebral Pulsatile Flow  0.679 (0.088)   0.678 (0.074)   0.671 (0.079) 
MCA Peak Systolic CBFv (cm/s) 86.7 (13.6)   90.6 (13.7)*†              86.4 (15.2) 
MCA Mean CBFv (cm/s)  62.4 (10.4)   65.3 (10.8) *†              62.4 (11.0) 
MCA Diastolic CBFv (cm/s)  44.5 (7.8)   46.8 (7.3)  44.7 (7.7) 
ICA Pulsatile Flow (cm/s)                      0.683 (0.102)                   0.678 (0.100)                0.665 (0.078) 
ICA Peak Systolic CBFv (cm/s)            56.4 (7.3)                         55.1 (8.8)                      56.9 (7.0) 
ICA Mean CBFv (cm/s)                         39.8 (4.9)                         39.1 (5.4)                      40.7 (4.6) 
ICA Diastolic CBFv (cm/s)                    29.3 (3.8)                         28.6 (3.6)                      29.9 (3.4) 
cfPWV (m/s)                6.98 (0.71)   6.80 (0.66)  6.93 (0.74) 
crPWV (m/s)                8.98 (1.02)   8.53 (1.42)  8.68 (1.37) 
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Figure 4. Differences in Systolic Blood Pressure 
Differences are least square means adjusted for baseline systolic blood pressure condition order, gender and age.  
*Significantly different from SIT P<0.05. **Significantly different from SIT P<0.01.  
† Significantly different from EX30 P<0.05.  †† Significantly different from EX30 P<0.01. 
Values are reported as Mean (SD). *Significantly different from SIT P<0.05. **Significantly different from SIT P<0.01. † Significantly different 
from EX30 P<0.05. †† Significantly different from EX30 P<0.01 
4.4.2 Trajectories of blood pressure and heart rate after SIT, EX10 and EX30 
Systolic Blood Pressure 
A linear mixed model adjusting for condition order, gender and age revealed no significant 
condition by time interaction (P=0.23); therefore, condition effects were evaluated separately at 
the 30- and 60-minute post-session assessments, with adjustment for baseline systolic blood 
pressure, condition order, gender and age. Figure 4 displays differences from baseline to the 30- 
and 60-minute post-session assessments adjusted for baseline systolic blood pressure, condition 











Table 12 continued 
 61 
Systolic blood pressure did not differ by condition at the 30-minute post-session 
assessment. Compared to SIT, systolic blood pressure was nonsignificantly lower in EX10 (β =-
2.05 mmHg, P=0.11) and EX30 (β =-2.42 mmHg, P=0.07). EX10 and EX30 were not different 
(β =-0.37 mmHg, P=0.78). Of note, differences from SIT to EX30 were approaching significance 
with P<0.10. 
Systolic blood pressure differed by condition at the 60-minute post-session assessment. 
Systolic blood pressure was lower in EX10 (β =-3.40 mmHg, P=0.04) and in EX30 (β=-7.03 
mmHg, P<0.001) when compared to SIT and lower in EX30 compared to EX10 (β =-3.64 
mmHg, P=0.03).  
Diastolic Blood Pressure 
A linear mixed model adjusting for condition order, gender and age revealed no significant 
condition by time interaction (P=0.60); therefore, condition effects were evaluated separately at 
the 30- and 60-minute post-session assessments adjusted for baseline diastolic BP, condition 
order, gender and age. Figure 5 displays differences from baseline to the 30- and 60-minute 
post-session assessments adjusted for baseline diastolic BP. 
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Figure 5. Differences in Diastolic Blood Pressure 
 
 
Diastolic blood pressure did not differ by condition at the 30-minute post-session 
assessment. Compared to SIT, EX10 (β =-0.18 mmHg, P=0.89) and EX30 (β =-1.89 mmHg, 
P=0.17) were not different. EX30 was not different from EX10 (β =-1.71 mmHg, P=0.21).  
Diastolic blood pressure differed by condition at the 60-minute post-session assessment. 
Compared to SIT, diastolic blood pressure was not different in EX10 (β =-0.64 mmHg, P=0.54) 
but was lower in EX30 (β=-3.43 mmHg, P=0.001). Diastolic blood pressure was also lower in 
EX30 compared to EX10 (β =-2.79 mmHg, P=0.01).  
Mean Arterial Pressure 
A linear mixed model adjusting for baseline condition order, gender and age revealed no 
significant condition by time interaction (P=0.37); therefore, condition effects were evaluated 
Differences are least square means adjusted for baseline diastolic blood pressure, condition order, gender and age.  
*Significantly different from SIT P<0.05. **Significantly different from SIT P<0.01.  
† Significantly different from EX30 P<0.05. †† Significantly different from EX30 P<0.01. 
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separately at the 30- and 60-minute post-session assessments for baseline mean arterial pressure, 
condition order, gender and age. Figure 6 displays differences from baseline to the 30- and 60-
minute post-session assessments adjusted for baseline mean arterial pressure condition order, 
gender and age. 
 
 
Figure 6. Differences in Mean Arterial Pressure 
Mean arterial pressure did not differ by condition at the 30-minute post-session 
assessment. Compared to SIT, mean arterial pressure was not different in EX10 (β =-0.87 
mmHg, P=0.60) but was nonsignificantly lower in EX30 (β =-2.77 mmHg, P=0.09). EX30 was 
not different from EX10 (β =-1.90 mmHg, P=0.25). Of note, differences from SIT to EX30 were 
approaching significance with P<0.10. 
Mean arterial pressure differed by condition at the 60-minute post-session assessment. 
Compared to SIT, mean arterial pressure was not different in EX10 (β =-1.54 mmHg, P=0.19), 
Figure 6. Differences in Mean Arterial Pres ure 
Differences are least square means adjusted for baseline mean arterial pressure for baseline MAP, condition order, gender and age. 
*Significantly different from SIT P<0.05. **Significantly different from SIT P<0.01.  
† Significantly different from EX30 P<0.05. †† Significantly different from EX30 P<0.01. 
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Figure 7. Trajectories of Heart Rate. 
*Significantly different from SIT P<0.05. **Significantly different from SIT P<0.01.  
† Significantly different from EX30 P<0.05. †† Significantly different from EX30 P<0.01. 
but was lower in EX30 (β=-4.60 mmHg, P<0.001). Mean arterial pressure was lower in EX30 
compared to EX10 (β =-3.07 mmHg, P=0.01).  
Heart Rate 
A linear mixed model adjusting for condition order, gender and age revealed a significant 
condition by time interaction (P<0.0001).  Post-hoc testing revealed heart rate in EX10 
(P=0.001) and EX30 (P<0.0001) was significantly higher compared to SIT. Additionally, heart 
rate in EX30 was significantly higher compared to EX10 (P=0.0002). Heart rate responded in a 
dose-response manner such that heart rate was highest in EX30 and lowest in SIT. Figure 7 















4.4.3 Specific aim I: comparing trajectories of cerebrovascular pulsatile flow after SIT, 
EX10 and EX30 
The primary aim of this study was to compare trajectories of cerebrovascular pulsatile flow after 
SIT, EX10 and EX30. Pulsatility index of the MCA was automatically calculated (as difference 
between MCA peak systolic and diastolic flow velocities divided by mean flow velocity) by 
TCD and was used as a measure of cerebrovascular pulsatile flow. Similarly, pulsatility index of 
the ICA (as a measure of ICA pulsatile flow) was measured to better understand cerebral 
pulsatile flow, as ICA supplies the MCA. 
4.4.3.1 Cerebral pulsatile flow 
A linear mixed model adjusting for heart rate, condition order, gender and age revealed no 
significant condition by time interaction (P=0.50); therefore, condition effects were evaluated 
separately at the 30- and 60-minute post-session assessments adjusted for baseline 
cerebrovascular pulsatile flow, heart rate, condition order, gender and age. Figure 8 displays 
differences from baseline to the 30- and 60-minute post-session assessments adjusted for 
baseline MCA pulsatility index values, heart rate, condition order, gender and age. Of note, 
higher pulsatility index indicates less healthy cerebrovascular hemodynamics. 
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Figure 8. Differences in Cerebral Pulsatile Blood Flow. 
Differences are least square means adjusted for baseline cerebral pulsatile blood flow condition order, heart rate, gender and 




MCA pulsatility index did not differ by condition at the 30-minute post-session 
assessment. Compared to SIT, MCA pulsatility index was not different in EX10 (β=0.016, 
P=0.33) but was nonsignificantly higher in EX30 (β =0.032, P=0.08). MCA pulsatility index was 
not different in EX30 compared to EX10 (β =0.016, P=0.27). Of note, higher MCA pulsatility in 
EX30 compared to SIT approached significance with P<0.10. 
 MCA pulsatility index did not differ by condition at the 60-minute post-session 
assessment.  Compared to SIT, MCA pulsatility index was not different in EX10 (β =-0.007, 
P=0.59) or EX30 (β=-0.001, P=0.92). MCA pulsatility index was not different in EX10 
compared to EX30 (β=-0.006, P=0.64).  
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4.4.3.2 Pulsatile flow in the ICA 
Interestingly, pulsatile flow in the ICA had similar responses to those in the MCA. A linear 
mixed model adjusting for heart rate, condition order, gender and age revealed no significant 
condition by time interaction (P=0.25); therefore, condition effects were evaluated separately at 
the 30- and 60-minute post-session assessments adjusted for baseline ICA pulsatile flow, heart 
rate, condition order, gender and age. Figure 9 displays differences from baseline to the 30- and 
60-minute post-session assessments adjusted for baseline ICA pulsatile flow, heart rate, 
condition order, gender and age. 
 
Figure 9. Differences in ICA Pulsatility Index. 
Differences are least square means adjusted for baseline ICA pulsatile flow, heart rate, condition order, gender and age. 
ICA pulsatility index was used as a measure of pulsatile blood flow. No significant differences found. 
 
ICA pulsatility index did not differ by condition at the 30-minute post-session 
assessment.  Compared to SIT, ICA pulsatility index was not different in EX10 (β=0.027, 
P=0.26) and was nonsignificantly higher in EX30 (β =0.044, P=0.08). ICA pulsatility index was 
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not different in EX30 compared to EX10 (β =0.017, P=0.47). Of note, higher ICA pulsatility in 
EX30 compared to SIT approached significance with P<0.10. 
ICA pulsatility index did not differ by condition at the 60-minute post-session 
assessment.  Compared to SIT, ICA pulsatility index was not different in EX10 (β =-0.016, 
P=0.18) or EX30 (β=-0.0003, P=0.98). Compared to EX30, ICA pulsatility index was not 
different in EX10 (β =0.016, P=0.15).  
4.4.4 Specific aim II: comparing trajectories of peak systolic, mean, and diastolic CBFv 
after SIT, EX10 and EX30 
The second aim of this study was to compare trajectories of peak systolic, mean and diastolic 
CBFv  after SIT, EX10 and EX30. Additionally, peak systolic, mean and diastolic CBFv of the 
ICA, the supplying artery, were also measured and its trajectories after SIT, EX10 and EX30 are 
also reported in this section.  
4.4.4.1 MCA peak systolic, mean and diastolic CBFv 
Peak Systolic MCA CBFv 
A linear mixed model adjusting for heart rate, condition order, gender and age revealed no 
significant condition by time interaction (P=0.69); therefore, condition effects were evaluated 
separately at the 30- and 60-minute post-session assessments adjusted for baseline peak systolic 
MCA CBFv, heart rate, condition order, gender and age. Figure 10 displays differences from 
baseline to the 30- and 60-minute post-session assessments adjusted for baseline peak systolic 
MCA CBFv, heart rate, condition order, gender and age. 
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Figure 10. Differences in Peak Systolic MCA CBFv 
Differences are least square means adjusted for baseline peak systolic MCA CBFv, heart rate, condition order, 











Peak systolic MCA CBFv did not differ by condition at the 30-minute post-session 
assessment. Peak systolic MCA CBFv was not different from SIT in EX10 (β =-0.38 cm/s, 
P=0.86) or EX30 (β=0.44 cm/s, P=0.85) or when EX10 was compared to EX30 (β= 0.82 cm/s, 
P=0.69).  
Similarly, peak systolic MCA CBFv did not differ by condition at the 60-minute post-
session assessment. Peak systolic MCA CBFv was not different from SIT in EX10 (β=-0.48 
cm/s, P=0.83) or EX30 (β=-0.44 cm/s, P=0.85) or when EX10 was compared to EX30 (β= 0.03 
cm/s, P=0.99).  
Mean MCA CBFv 
A linear mixed model adjusting for heart rate, condition order, gender and age revealed no 
significant condition by time interaction (P=0.98); therefore, condition effects were evaluated 
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          Figure 11. Differences in Mean MCA CBFv 
Differences are least square means adjusted for baseline mean MCA CBFv, heart rate, condition order, gender 
and age. No significant differences found. 
separately at the 30- and 60-minute post-session assessments adjusted for baseline mean MCA 
CBFv, heart rate, condition order, gender and age. Figure 11 displays differences from baseline 
to the 30- and 60-minute post-session assessments adjusted for baseline mean MCA CBFv, heart 













Mean MCA CBFv did not differ by condition at the 30-minute post-session assessment. 
Mean MCA CBFv was not different from SIT in EX10 (β =-0.41 cm/s, P=0.80) or EX30 (β=-
1.02 cm/s, P=0.55) or when EX10 was compared to EX30 (β=0.60 cm/s, P=0.69).  
Similarly, mean MCA CBFv did not differ by condition at the 60-minute post-session 
assessment. Mean MCA CBFv was not different from SIT in EX10 (β=-0.01 cm/s, P=1.00) or 
EX30 (β=-0.43 cm/s, P=0.81) or when EX10 was compared to EX30 (β=0.42 cm/s, P=0.80).  
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Figure 12 Differences in Diastolic MCA CBFv 
Differences are least square means adjusted for baseline diastolic MCA CBFv, heart rate, condition order, 
gender and age. No significant differences found. 
Diastolic MCA CBFv 
A linear mixed model adjusting for heart rate, condition order, gender and age revealed no 
significant condition by time interaction (P=1.00); therefore, condition effects were evaluated 
separately at the 30- and 60-minute post-session assessments adjusted for baseline diastolic 
MCA CBFv, heart rate, condition order, gender and age. Figure 12 displays differences from 
baseline to the 30- and 60-minute post-session assessments adjusted for baseline diastolic MCA 












Diastolic MCA CBFv did not differ by condition at the 30-minute post-session 
assessment. Diastolic MCA CBFv was not different from SIT in EX10 (β =-0.29 cm/s, P=0.80) 
or EX30 (β=-0.73 cm/s, P=0.56) or when EX10 was compared to EX30 (β=0.43 cm/s, P=0.70).  
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Figure 13. Differences in peak systolic ICA CBFv 
Differences are least square means adjusted for baseline peak systolic ICA CBFv, heart rate, condition order, gender 
and age. No significant differences found. 
Similarly, diastolic MCA CBFv did not differ by condition at the 60-minute post-session 
assessment.  Diastolic MCA CBFv was not different from SIT in EX10 (β=0.72 cm/s, P=0.56) or 
EX30 (β=0.28 cm/s, P=0.83) or when EX10 was compared to EX30 (β=0.44 cm/s, P=0.71).  
4.4.4.2 ICA CBFv  
Peak Systolic ICA CBFv 
A linear mixed model adjusting for heart rate, condition order, gender and age revealed a 
condition by time interaction (P=0.07) approaching significance (however, not statistically 
significant); therefore, condition effects were evaluated separately at the 30- and 60-minute post-
session assessments baseline peak systolic ICA CBFv, heart rate, condition order, gender and 
age. Figure 13 displays differences from baseline to the 30- and 60-minute post-session 









Peak systolic ICA CBFv did not differ by condition at the 30-minute post-session 
assessment.  Compared to SIT, peak systolic ICA CBFv was nonsignificantly higher in EX10 (β 
=2.85 cm/s, P=0.06) but not different from EX30 (β=2.05 cm/s, P=0.21).  Peak systolic ICA 
CBFv was not different in EX10 compared to EX30 (β=0.81 cm/s, P=0.56). Of note, the higher 
peak systolic ICA CBFv in EX10 compared to SIT was approaching significance with P<0.10. 
Similarly, peak systolic ICA CBFv did not differ by condition at the 60-minute post-
session assessment. Compared to SIT, peak systolic ICA CBFv was not different in EX10 
(β=0.48 cm/s, P=0.83) or EX30 (β=-1.28 cm/s, P=0.39). Peak systolic ICA CBFv was 
nonsignificantly lower in EX30 compared to EX10 (β=-2.72 cm/s, P=0.06). Of note, lower peak 
systolic ICA CBFv in EX30 compared to EX10 was approaching significance with P<0.10.  
Mean ICA CBFv 
A linear mixed model adjusting for heart rate, condition order, gender and age revealed no 
significant condition by time interaction (P=0.36); therefore, condition effects were evaluated 
separately at the 30- and 60-minute post-session assessments adjusted for baseline mean ICA 
CBFv, heart rate, condition order, gender and age. Figure 14 displays differences from baseline 
to 30- and 60-minute post-session assessments adjusted for baseline mean ICA CBFv, heart rate, 





Figure 14. Differences in Mean ICA CBFv 
Differences are least square means adjusted for baseline mean ICA CBFv, heart rate, condition order, gender and age
 *Significantly different from SIT P<0.05. **Significantly different from SIT P<0.01.  











Mean ICA CBFv did not differ by condition at the 30-minute post-session assessment. 
Compared to SIT, mean ICA CBFv was not different from EX10 (β =1.34 cm/s, P=0.16) or 
EX30 (β=0.34 cm/s, P=0.75). Mean ICA CBFv not different in EX30 compared to EX10 (β=-
1.00 cm/s, P=0.25). 
Mean ICA CBFv differed by condition at the 60-minute post-session assessment. 
Compared to SIT, mean ICA CBFv was nonsignificantly higher in EX10 (β=2.07 cm/s, P=0.08) 
but not different from EX30 (β=-0.30 cm/s, P=0.82). Of note, the higher mean ICA CBFv in 
EX10 compared to SIT was approaching significance with P<0.10.  Mean ICA CBFv was lower 
in EX30 compared to EX10 (β=-2.36 cm/s, P=0.04). 
Diastolic ICA CBFv 
A linear mixed model adjusting for baseline diastolic ICA CBFv, heart rate, condition order, 
gender and age revealed no significant condition by time interaction (P=0.16); therefore, 
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Figure 15. Differences in diastolic ICA CBFv. 
Differences are least square means adjusted for baseline diastolic ICA CBFv, heart rate, condition order, gender and age. 
*Significantly different from SIT P<0.05. **Significantly different from SIT P<0.01.  
† Significantly different from EX30 P<0.05. †† Significantly different from EX30 P<0.01. 
condition effects were evaluated separately at the 30- and 60-minute post-session assessments 
adjusted baseline diastolic ICA CBFv, heart rate, condition order, gender and age. Figure 15 
displays differences from baseline to 30- and 60-minute post-session assessments adjusted for 













Diastolic ICA CBFv did not differ by condition at the 30-minute post-session assessment 
Compared to SIT, diastolic ICA CBFv was nonsignificantly higher in EX10 (β =1.23 cm/s, 
P=0.07) but not different in EX30 (β=0.41 cm/s, P=0.56). Diastolic ICA CBFv was not different 
in EX30 compared to EX10 (β=-0.82 cm/s, P=0.20). Of note higher diastolic ICA CBFv in EX10 
compared to SIT was approaching significance with P<0.10. 
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 Diastolic ICA CBFv differed by condition at the 60-minute post-session assessment. 
Compared to SIT, diastolic ICA CBFv was nonsignificantly higher in EX10 (β=1.21 cm/s, 
P=0.08) but not different in EX30 (β=-0.63 cm/s, P=0.39). Of note, higher diastolic ICA CBFv 
in EX10 compared to SIT was approaching significance with P<0.10. Diastolic ICA CBFv was 
lower in EX30 compared to EX10 (β=-1.84 cm/s, P=0.01).  
4.4.5 Specific aim III: comparing trajectories of arterial stiffness after SIT, EX10 and 
EX30 
The third aim of this study was to compare trajectories of arterial stiffness after SIT, EX10 and 
EX30. Measures of arterial stiffness included central (cfPWV) and peripheral (crPWV) PWV as 
well as pulse pressure calculated as systolic blood pressure minus diastolic blood pressure. 
cfPWV 
A linear mixed model adjusting for condition order, gender and age revealed no significant 
condition by time interaction (P=0.46); therefore, condition effects were evaluated separately at 
the 30- and 60-minute post-session assessments adjusted baseline cfPWV, condition order, 
gender and age. Figure 16 displays differences from baseline to the 30- and 60-minute post-
session assessments adjusted for baseline cfPWV, condition order, gender and age. 
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Figure 16. Differences in cfPWV 
Differences are least square means adjusted for baseline cfPWV, condition order, gender and age. 
*Significantly different from SIT P<0.05. **Significantly different from SIT P<0.01 











cfPWV differed by condition at the 30-minute post-session assessment. Compared to 
SIT, cfPWV was higher in EX10 (β =0.30 m/s, P=0.02) but not different in EX30 (β =-0.01 m/s, 
P=0.95). cfPWV was lower in EX30 compared to EX10 (β =-0.30 m/s, P=0.02).  
cfPWV did not differ by condition at the 60-minute post-session assessment. Compared 
to SIT, cfPWV was not different in EX10 (β =0.004 m/s, P=0.97) or EX30 (β=0.02 m/s, P=0.89) 
or when EX10 was compared to EX30 (β =0.01 m/s, P=0.92).  
crPWV 
A linear mixed model adjusting for condition order, gender and age revealed no significant 
condition by time interaction (P=0.18); therefore, condition effects were evaluated separately at 
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Figure 17. Differences in crPWV 
Differences are least square means adjusted for baseline crPWV, condition order, gender and age. 
*Significantly different from SIT P<0.05. **Significantly different from SIT P<0.01.  
† Significantly different from EX30 P<0.05. †† Significantly different from EX30 P<0.01 
the 30- and 60-minute post-session assessments baseline crPWV, condition order, gender and 
age. 
Figure 17 displays differences from baseline to the 30- and 60-minute post-session assessments 












crPWV did not differ by condition at the 30-minute post-session assessment. Compared 
to SIT, crPWV did not differ from EX10 (β =0.10 m/s, P=0.77) or EX30 (β =-0.28 m/s, P=0.41).  
crPWV was not different in EX30 compared to EX10 (β =-0.39 m/s, P=0.26).  
crPWV differed by condition at the 60-minute post-session assessment. Compared to 
SIT, crPWV was lower in EX10 (β =-0.88 m/s, P=0.004) but not different in EX30 (β=-0.45 m/s, 
P=0.14). crPWV was not different in EX30 compared to EX10 (β =0.44 m/s, P=0.15).  
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Figure 18. Differences in Pulse Pressure 
Differences are least square means adjusted for baseline pulse pressure, condition order, gender and age 
. *Significantly different from SIT P<0.05. **Significantly different from SIT P<0.01.  
† Significantly different from EX30 P<0.05. †† Significantly different from EX30 P<0.01. 
Pulse Pressure 
A linear mixed model adjusting for baseline condition order, gender and age revealed no 
significant condition by time interaction (P=0.45); therefore, condition effects were evaluated 
separately at the 30- and 60-minute post-session assessments adjusted for baseline pulse 
pressure, condition order, gender and age. Figure 18 displays differences from baseline to the 
30- and 60-minute post-session assessments adjusted for baseline pulse pressure, condition order, 















Pulse pressure did not differ by condition at the 30-minute post-session assessment. 
Compared to SIT, pulse pressure was not different in EX10 (β =-1.88 mmHg, P=0.13) or EX30 
(β =-0.60 mmHg, P=0.63). Pulse pressure was not different in EX30 compared to EX10 (β =1.28 
mmHg, P=0.31).   
Pulse pressure differed by condition at the 60-minute post-session assessment. Compared 
to SIT, pulse pressure was lower in EX10 (β =-2.79 mmHg, P=0.01) and in EX30 (β=-3.85 
mmHg, P=0.001). Pulse pressure was not different in EX30 compared to EX10 (β =-1.06 mmHg, 
P=0.35).  
4.4.6 Specific aim IV: evaluating relationships between changes in cerebral pulsatile flow 
and changes in arterial stiffness 
The fourth aim of the study was to evaluate relationships between changes in cerebral pulsatile 
flow and changes in arterial stiffness. Linear mixed models adjusting for baseline cerebral 
pulsatile flow, heart rate, condition order, age and gender were performed. Changes in cfPWV 
were not related to changes in cerebral pulsatile flow at the 30-minute post-session assessment 
(B=-0.02, P=0.30) or at the 60-minute post-session assessment (B= -0.006, P=0.73). Similarly, 
changes in crPWV were not related to changes in cerebral pulsatile flow at the 30-minute post-
session assessment (B=-0.005, P=0.37) or at the 60-minute post-session assessment (B= -0.004, 
P=0.48). Changes in pulse pressure, however, were directly related to increases in cerebral 
pulsatile flow at the 30-minute post-session assessment (B=0.004, P=0.02) but not at the 60-
minute post-session assessment (B= 0.0008, P=0.59). Figure 19 displays the relationship 
between cerebral pulsatile flow and pulse pressure at the 30-minute post-session assessment.  
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Figure 19. Relationship Between Cerebral Pulsatile Flow and Pulse 














5.0  DISCUSSION 
5.1 SUMMARY OF FINDINGS 
The purpose of this study was to evaluate acute effects of aerobic exercise on cerebrovascular 
hemodynamics and arterial stiffness. This study used a randomized crossover design comprised 
of three separate experimental visits, each with a different experimental session: 30 minutes of 
sitting (SIT), 20 minutes of sitting followed by a 10-minute exercise bout (EX10) and a 30-
minute exercise bout (EX30). Cerebrovascular hemodynamics and arterial stiffness were 
measured before the experimental session and at 30- and 60-minute post-session assessments. 
We hypothesized that cerebrovascular hemodynamics and arterial stiffness would respond such 
that these outcomes would be most improved in EX30 and least in SIT. Our goal was to keep the 
intensity of the aerobic exercise bouts in the moderate-to-vigorous range to isolate a duration 
effect of exercise. Exercise parameters (speed, grade) were comparable between EX10 and 
EX30, and heart rates averaged between 70-75% of age-predicted maximum heart rate (our 
target) which strengthens our findings.  
 Systolic, diastolic and mean arterial blood pressure responded in an expected dose-
response manner at both the 30- and 60-minute post-session assessments. Specifically, blood 
pressures were highest in SIT and lowest in EX30, with these differences approaching or 
reaching statistical significance, particularly when comparing EX30 to SIT. There was a 
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significant condition by time interaction such that heart rate changed differently across 
conditions. Heart rate decreased in SIT and increased in EX10 and EX30, with greater increases 
in EX30 at both the 30-and 60-minute post-session assessments. These results are consistent with 
other studies reporting an acute hypotensive effect of aerobic exercise as well as acute increases 
in heart rate to compensate for excess post-exercise oxygen consumption [165-167]. 
Furthermore, these results suggest our stimuli were appropriate as they resulted in dose-response 
cardiovascular effects. 
The primary aim of this study was to compare trajectories of cerebral pulsatile flow after 
SIT, EX10 and EX30. There were no significant condition effects at the 30- or 60-minute post-
session assessments. However, cerebral pulsatile flow was higher in EX30 compared to SIT at 
the 30-minute post-session assessment and this difference was approaching statistical 
significance (4.7% higher, P=0.08). Similar changes were observed in ICA pulsatile flow such 
that it was higher at 30-minute post-session assessment in EX30 compared to SIT and this 
increase was also approaching statistical significance (6.5% higher, P=0.08). 
The second aim of the study was to compare trajectories of additional MCA 
cerebrovascular hemodynamic measures including peak systolic, mean and diastolic CBFv. 
There were no significant condition effects at the 30- or 60-minute post-session assessments. In 
contrast, ICA peak systolic, mean and diastolic CBFv had borderline and significant differences 
such that post-session assessment blood flow velocity values were higher in EX10 but not in 
EX30.   
The third aim of the study was to compare trajectories of arterial stiffness measures after 
SIT, EX10 and EX30. cfPWV (central) was significantly higher in EX10 compared to SIT (0.30 
m/s higher, P=0.02) and EX30 (0.30 m/s higher, P=0.02), while there was no difference between 
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EX30 versus SIT at the 30-minute post-session assessment. Furthermore, cfPWV did not differ 
across condition at the 60-minute post-session assessment. crPWV (peripheral) was not different 
across conditions at the 30-minute post-session assessment. In contrast, crPWV was significantly 
lower in EX10 compared to SIT at the 60-minute post-session assessment (0.88 m/s lower, 
P=0.004). Pulse pressure was significantly lower in EX10 (2.8 mmHg lower, P=0.01) and EX30 
(3.9 mmHg lower, P=0.001) compared to SIT at the 60-minute post-session assessment but did 
not differ by condition at the 30-minute post-session assessment. 
 The final and fourth aim of the study was to evaluate relationships between changes in 
cerebral pulsatile flow and arterial stiffness. Increases in pulse pressure were significantly related 
to increases in cerebral pulsatile flow at the 30- but not 60-minute post-session assessments. 
Neither changes in cfPWV nor crPWV were related to changes in cerebral pulsatile flow. 
  
5.2 ACUTE EFFECTS OF EXERCISE ON PULSATILE FLOW  
We hypothesized that cerebral pulsatile flow would decrease due to exercise-induced reductions 
in arterial stiffness, allowing for better cushioning of the pulsatile flow created by the heart, thus 
reducing pulsatile flow reaching the brain. Our results, however, did not support our hypothesis. 
We found cerebral pulsatile flow to have nonsignificant, dose response effects at the 30-minute 
post-session assessment with differences between SIT and EX30 approaching significance. 
Cerebral pulsatile flow was 2.4% higher beyond SIT following EX10 and 4.7% higher beyond 
SIT following EX30. We also found cerebral pulsatile flow was not different across conditions at 
the 60-minute post-session assessment with differences ≤ 1.1%. Additionally, we found pulsatile 
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flow in the ICA to have very similar responses such that ICA pulsatile flow was 4.1% higher 
beyond SIT following EX10 and 6.5% higher beyond SIT following EX30 at the 30-minute post-
session assessment. Moreover, ICA pulsatile flow was a 2.4% lower in EX10 and 0.3% in EX30 
compared to SIT at the 60-minute post-session assessment.  
 To the best of our knowledge, this is the first study to evaluate the acute effects of 
aerobic exercise on cerebral pulsatile flow. There are, however, studies evaluating cerebral 
pulsatile flow during exercise that may aid in the interpretation of our results. During 15 minutes 
of moderate intensity cycling in healthy young adults (n=14), pulsatility index was found to 
increase by 49% and 43% from baseline in the right and left MCA, respectively [168]. Similarly, 
during 3 minutes of pedaling an ergometer, young healthy adults (n=18) had a 24%, 18% and 
16% increase in pulsatility index during minutes 1, 2 and 3, respectively. Furthermore, pulsatility 
index remained 20%, 8%, and 8% above baseline at recovery minutes 1, 2 and 3, respectively 
[169]. Our results are consistent with these studies and suggest pulsatility index increases during 
aerobic exercise and may remain elevated for up to 30 minutes following the exercise bout, 
returning to baseline by 60 minutes following exercise. Thus, while the clinical significance of 
the post-exercise increase in cerebral pulsatile flow is unclear, the magnitude of the increase 
appears to be transient and lower post-exercise as compared to during exercise. 
The acute increases in cerebral pulsatile flow are likely to occur due to exercise-induced 
increases in cardiac output and pulse pressure, inherently increasing pulsatile flow [170-172]. It 
has also been proposed that pulsatility increases due to vasoconstriction of the MCA [169]. 
Though that may be the case during exercise, it is unlikely to be the case in the present study of 
post-exercise effects because we did not observe an increase in MCA CBFv at either assessment 
(as would be the expected with vasoconstriction).  
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Another potential mechanism which could explain why no significant reductions in 
cerebral pulsatile flow were observed is that we did not see the hypothesized reductions in PWV 
(specific aim III). Additionally, we found changes in cfPWV and crPWV were not related to 
changes in cerebral pulsatile flow. Not supporting this mechanism, however, is that we did 
observe reductions in pulse pressure and these changes were significantly related to cerebral 
pulsatile flow at 30- but not 60-minute post-session assessments. Though cerebral pulsatile flow 
was not lower during the hour following exercise, our results do provide novel evidence that 
acute changes in pulse pressure following aerobic exercise are directly related to cerebral 
pulsatile flow.  
Another possibility is that acute changes in cerebral pulsatile flow following aerobic 
exercise do not occur until after our 60-minute observation period. For example, vascular 
benefits of a single bout of exercise may last up to 24 hours [145, 166]. Though this study is the 
first to evaluate post-exercise effects on cerebral pulsatile flow up to 60 minutes, it is possible 
that reductions in pulsatile flow could occur beyond 60 minutes. Yet another reason could be a 
floor effect. Our participants were healthy middle-aged adults, were active on average and had a 
baseline pulsatility index value of 0.67 (averaged across conditions), which is well below the 
clinical value for pulsatile flow of 1.2 [45]. Thus, it may be the case that their cerebral pulsatile 
flow could not get much lower. 
Though there are no comparable studies evaluating acute relationships of cerebral 
pulsatile flow and arterial stiffness following exercise (specific aim IV), our findings are in line 
with other research. Cerebral pulsatile flow of the MCA has been shown to be more pulsatile in 
the presence of arterial stiffness. This relationship has been reported with both PWV and pulse 
pressure (central and peripheral) [4, 5]. Furthermore, decreases in arterial stiffness (increases in 
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carotid arterial compliance) were significantly associated with decreases in cerebral pulsatile 
flow following a 16-week endurance training intervention [6]. Thus, it may be that PWV is not 
related to cerebral pulsatile flow acutely but it is overtime. 
5.2.1 Significance and future directions 
In summary, and contrary to our hypothesis, we found cerebral pulsatile flow to be marginally 
higher in EX30 compared to SIT at the 30-minute post-session assessment and back to baseline 
at the 60-minute post-session assessment. Additionally, changes in cerebral pulsatile flow at the 
30-minute post-session assessment were related to changes in pulse pressure.  
Based on our results, aerobic exercise does not have acute benefits on cerebral pulsatile 
flow within an hour of an exercise bout. However, investigation of methods to reduce cerebral 
pulsatile blood flow, thereby reducing cerebrovascular disease risk, remains important. Exercise-
induced reductions in arterial stiffness have been proposed as a method to reduce cerebral 
pulsatile flow and these outcomes [61, 92], at least with pulse pressure, were positively related in 
our study. Thus, further research with a longer duration of exercise, a longer observational period 
and characterization of the relationship of cerebral pulsatile flow and arterial stiffness following 
exercise is warranted. 
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5.3 ACUTE EFFECT OF EXERCISE ON PEAK SYSTOLIC, MEAN, AND 
DIASTOLIC CBFV  
We hypothesized that MCA CBFv would increase acutely following exercise. Our results, 
however, did not support our hypothesis. Peak systolic, mean and diastolic MCA CBFv were not 
different from SIT in EX10 or EX30 at 30- or 60-minute post-session assessments. In fact, 
changes in peak systolic, mean and diastolic CBFv only differed by ≤1.6% in EX10 and EX30 as 
compared to SIT.  
 Our hypotheses were based on cross sectional studies that have established higher CBF 
in those with higher physical activity and cardiorespiratory fitness [115-119], intervention 
studies reporting that resting CBF increases following exercise interventions [48, 120, 121],  
accumulating evidence demonstrating CBF increases during exercise [173] and preliminary 
evidence suggesting increased CBF following exercise [122]. Specifically, global CBF was 
found to increase by 20% using arterial spin labeling (ASL) following 30 minutes of moderate 
intensity cycling in young healthy adults (n=5) [122].  
However, the current literature describing the acute effects of aerobic exercise on CBF is 
inconsistent with studies reporting acute increases, decreases and no change in CBF following 
exercise. [123-126, 128]. Inconsistent results across studies may be due to small sample sizes or 
differences in neuroimaging methodology, measurement of different cerebral vessels or regions, 
variable duration and intensity of the exercise stimulus and post-exercise observation period. Our 
results are consistent with studies evaluating cerebrovascular hemodynamics following a 30- and 
a 40-minute bout of exercise as well as a marathon. Following a 40-minute cycling bout, MCA 
CBFv did not change from baseline to 10-, 30- or 60-post-exercise in twelve young healthy 
adults [127]. Similarly, following a 30-minute cycling bout with stepwise intensity increases 
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(starting at ~20% and ending at 80-90% of max capacity), MCA CBFv did not change 
significantly from baseline to six minutes post-exercise in seven healthy adults [128].  MCA 
CBFv was also unchanged within four hours of a mountain marathon in nine healthy adults 
[129].  
It is unlikely the results in the present study are due to insufficient exercise exposure as 
we found dose-response effects on blood pressure and heart rate consistent with the literature 
[165-167], but several mechanisms could explain our null results. Most of the aforementioned 
studies have focused on young, healthy individuals who are likely to have healthy cerebral blood 
flow; studies with null results may reflect a ceiling effect. The lack of an acute effect of exercise 
on CBFv in our study that included middle-aged, healthy adults could also be due to a ceiling 
effect. Our nonsignificant changes in cerebrovascular hemodynamics could perhaps be due to a 
time course where MCA CBFv returns to baseline before 30 minutes post-exercise. Lastly, our 
results could be explained by cerebral autoregulation.  Autoregulation refers to the ability of the 
brain to maintain a relatively constant supply of CBF despite changes in blood pressure and a 
wide range of metabolic demands from neuronal tissue. According to autoregulation, CBF 
should not change unless blood pressure falls outside of 60mmHg to 150mmHg [174], which 
was not the case in our participants at 30 or 60 minutes post-exercise.  
Our null results do not eliminate the possibility that there are acute changes in 
cerebrovascular hemodynamics due to exercise. There could be changes in the more distal 
microvasculature which would not be captured by the TCD as we measured parent MCA, at the 
ICA bifurcation. Other neuroimaging methods (such as ASL and NIRS) may be able to capture 
changes in the microvasculature as these methodologies provide information on brain regions, 
not specific vessels. It may be that there are microvascular changes first, and, over time these 
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changes extend to the larger conduit vessels. Or it could be that the larger parent vessels can 
better tolerate changes in how blood is being introduced to the brain. This could explain why 
there seem to be acute global increases following exercise using ASL but not with TCD. 
Furthermore, TCD indirectly measures CBF by measuring blood flow velocity, and thus could 
fail to capture changes in blood flow if there were concomitant changes to vessel diameter [46]. 
5.3.1 Significance and future directions 
In summary, and contrary to our hypotheses, we did not find differences in MCA peak systolic, 
mean or diastolic CBFv across conditions at the 30- or 60-minute post-session assessments. 
Based on our results, aerobic exercise does not have acute benefits on MCA cerebrovascular 
hemodynamics within an hour of an exercise bout. One implication is that our findings do not 
support increased MCA CBFv as a potential mechanism of cognitive improvement following 
exercise. Future research should evaluate less healthy and older populations, measure CBF more 
proximally to the exercise bout, and simultaneously measure different cerebral regions and 
vessels to improve our understanding of acute exercise effects on CBF. 
5.4 ACUTE EFFECT OF EXERCISE ON ARTERIAL STIFFNESS 
We hypothesized that arterial stiffness would decrease following EX10 and EX30 as both central 
and peripheral arterial stiffness have been shown to decrease following aerobic exercise [17, 18, 
149]. Aerobic exercise increases the availability of NO, leading to a reduction in vascular smooth 
muscle cell tone, improved arterial function and vasodilation [17, 175]. Additionally, it has been 
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proposed that acute changes in arterial stiffness following aerobic exercise are a result of changes 
in the intrinsic properties of the arterial wall [17, 131]. We further hypothesized that, like blood 
pressure, there would be dose-response effects on arterial stiffness such that EX30 would have 
the largest improvement. Because effects on PWV differed substantially between EX10 and 
EX30, the results are discussed separately below. 
5.4.1 Arterial stiffness following EX30 
Our results did not support our hypotheses. We found no significant differences in cfPWV at 30- 
or 60-minute post-exercise following EX30 compared to SIT. These results are similar to studies 
reporting no change in cfPWV following aerobic exercise at 30 [150-153] and 60 minutes [151-
154] post-exercise. Furthermore, a systematic review reported additional studies evaluating other 
measures of arterial stiffness have found similar nonsignificant results measured 10-60 minutes 
following exercise [157].  In contrast, a few studies have found cfPWV to decrease 20 to 50-
minutes following exercise [17, 18, 149]. These inconsistent results may be due to differences in 
duration, intensity and modality of exercise or population characteristics.  
There are fewer studies evaluating the acute effect of exercise on peripheral PWV. 
Though not significant, we found crPWV to be marginally lower 30 and 60 minutes following 
EX30 compared to SIT. One study also found nonsignificant decreases in crPWV from 6-28 
minutes following a moderate-to-vigorous intensity, 30-minute cycling bout [176]. Similarly, 
brachial-radial PWV was found to be significantly lower every minute post-exercise for 60-
minute following a maximal treadmill test [177].   
Even fewer studies have evaluated acute effects of exercise on pulse pressure. We found 
differences in pulse pressure from baseline to be significantly lower 60 minutes following EX30 
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compared to SIT. One study reported a significant decrease from baseline in pulse pressure at 20-
minutes and 50-minutes following a 60-minute exercise bout [149].  
Our nonsignificant results of cfPWV and crPWV could partly be explained by changes in 
blood pressure following EX30. Blood pressure is known to influence arterial stiffness [61], and 
we did not observe large differences from SIT in blood pressure 30 minutes following EX30. 
Systolic blood pressure was 2.4 mmHg lower and diastolic blood pressure was 1.9 mmHg lower 
than SIT at the 30-minute post-session assessment. However, larger reductions in blood pressure 
were observed at 60 minutes following EX30.  Systolic blood pressure was 7.0 mmHg lower and 
diastolic blood pressure was 3.4 mmHg lower than SIT at the 60-minute post-session assessment. 
These blood pressures are consistent with average post-exercise decreases which have been 
reported to be 8mmHg in systolic blood pressure and 9mmHg in diastolic blood pressure in 
normotensive individuals [167]. Others report reductions of 5-10mmHg [166].  Thus, it is 
unlikely that our 60-minute results reflect an inadequate hypotensive response. 
It also might be the case that exercise-induced acute changes in arterial stiffness do not 
occur within an hour following exercise, but perhaps occur between an hour and 24 hours after 
the exercise bout. Previous studies have reported significant reductions in arterial stiffness 24 
hours following aerobic exercise[145, 178]; however our study only measured an hour following 
exercise.   
5.4.2 Arterial stiffness following EX10 
To the best of our knowledge, the present study is the first to report the acute effects of a 10-
minute bout of aerobic exercise on arterial stiffness. We found cfPWV was significantly higher 
30 minutes following EX10 when compared to SIT and EX30. Additionally, we found crPWV to 
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be significantly lower 60 minutes following EX10 when compared to SIT. Of note, neither 
cfPWV nor crPWV differed from SIT at either post-session assessment. The most similar study 
evaluated waveforms of the carotid and radial arteries following 15 minutes of moderate 
intensity cycling. The study found augmentation index increased significantly 10-minutes post-
exercise [179], which represents higher arterial stiffness. This is consistent with our findings at 
the 30-minute post-session assessment but was measured more proximally to the exercise bout. 
The mechanism behind these EX10 induced results are unclear. Previous studies have 
demonstrated that intermittent 10-minute bouts of exercise are not as effective as a 30-minute 
continuous bout at improving cardiorespiratory fitness, suggesting the physiology is different 
during longer durations of continuous aerobic exercise [102, 180, 181]. Thirty minutes of 
exercise may allow for true steady state and homeostasis, while a 10-minute bout may allow for 
only 5-7 minutes of steady state. This shorter duration of steady state may not be enough to alter 
the physiological properties that influence PWV [181].  Thus, a 10-minute exercise bout may 
affect the factors involved in arterial stiffness such as NO bioavailability, other vasodilators, 
vasoconstrictors, inflammatory molecules, reactive oxygen species and antioxidants differently 
than a 30-minute bout [175].  
A specific potential explanation for these results could be that bouts of exercise shorter 
than 30 minutes elicit inconsistent changes in blood pressure and do not result in hypotension 
following exercise in normotensive individuals [166], which could lead to inconsistent responses 
in PWV. We found blood pressure was not different in EX10 as compared to SIT or EX30, and 
thus unlikely to explain the higher cfPWV in EX10, at the 30-minute post-session assessment. At 
the 60-minute post-session assessment, crPWV was significantly lower in EX10 compared to 
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SIT while EX30 was not. Again, these results do not mimic the dose-response patterns we 
observed with blood pressure, arguing against this potential mechanism. 
A final possible explanation may be differences in timing from initiation of exercise. At 
the 30-minute post-session assessment, a participant would have initiated exercise 40 minutes 
prior in EX10 and 60 minutes prior in EX30. We are not able to evaluate this possibility as we 
chose to anchor post-session assessments from the time of exercise completion. 
5.4.3 Significance and future directions 
In summary, and contrary to our hypotheses, neither cfPWV nor crPWV were lower than SIT 
following EX30. Following EX10, cfPWV was higher than SIT at the 30-minute post-session 
assessment.  Furthermore, crPWV was lower than SIT at the 60-minute post-session assessment. 
Pulse pressure was lower following exercise (EX10 and EX30) at the 60 but not the 30-minute 
post-session assessment. Based on our results, exercise bouts of 10 and 30 minutes in duration 
have differential effects on cfPWV and crPWV. The mechanisms responsible for these 
differential effects, and especially physiological responses to 10-minute bouts of exercise, 
warrant further research. Given that the minimum recommended bout duration is 10 minutes [15, 
16], such research could have important public health implications. 
5.5 STRENGTHS AND LIMITATIONS 
Strengths of this study include the randomized crossover design and standardization of the 
protocol as well as timing to account for known diurnal variations in CBFv. We used a 30-
 95 
minute exercise bout as this is the daily recommended duration of aerobic exercise by the 
American College of Sports Medicine. Moreover, we used a 10-minute exercise bout as that is 
the minimum duration of aerobic exercise recommended by the American College of Sports 
Medicine to accumulate 30 minutes of exercise [15, 16]. We used PWV to measure arterial 
stiffness, which is the gold standard. Additionally, we used TCD to measure cerebrovascular 
hemodynamics, which is widely used and has an excellent temporal resolution. We measured 
cerebrovascular hemodynamics of the MCA, the most measured cerebral artery, as well as at the 
ICA to capture a more comprehensive picture of cerebrovascular hemodynamic responses.  
Furthermore, a sole sonographer performed all TCD and PWV measurements, thus eliminating 
inter-rater variability, to which TCD is particularly sensitive. Another strength in our study is our 
sitting control condition (SIT) to which we compared the exercise sessions. This control 
condition allowed us to account for diurnal variations that are not normally accounted for in 
quasi-experimental studies relying on single-group pre- to post-intervention assessments. 
Limitations of the study include the small sample size and a lack of measurement of other 
factors that could affect cerebrovascular hemodynamics such as PaCO2 [173]. Additionally, this 
was an acute laboratory study, and thus generalizability in a real-world setting is limited. 
Furthermore, caution should be taken when interpreting the results as clinically meaningful, as 
this was an acute laboratory study. The observed effects may simply be transient returns to 
homeostasis following the removal of the physiological load imposed by acute exercise rather 
than clinically meaningful effects that could result from habitual bouts of exercise. Moreover, 
TCD provides CBFv which is an indirect measure of CBF [46]. Moreover, the TCD sonographer 
held the TCD probe in place for each minute-long recording, and thus sonographer hand 
movement and/or participant head movement could have also affected results. Additionally, 
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vascular outcomes were assessed at limited time points (30- and 60-minute post-sessions), thus 
potentially missing changes that could be captured with more frequent assessments and using a 
longer observation period. Our results could also be spurious due to multiple comparisons 
without Bonferroni adjustments. Given our small sample size and many outcomes at various time 
points and multiple conditions, we did not use such adjustments.  
The experimental arrangement also had its limitations. Participants were asked to abstain 
from caffeine for 24 hours and from food for 4 hours to comply with vascular and exercise 
testing recommendations. This, combined with the extended amount of time they spent in a 
supine position (60-minute post experimental session), caused most participants to become 
sleepy, with some participants falling asleep during the rest intervals between assessments. 
Additionally, the time of day of the experiment (between 11:40am and 5:00pm) could have 
contributed to sleepiness as there is a reduction in alertness and increased sleepiness during this 
time frame [182]. Moreover, acute exercise is known to induce sleepiness [183]. Thus, 
exercising during this sensitive period could have a synergistic effect and could induce sleep 
even more. Participants becoming sleepy and/or falling asleep during supine rest prior to and/or 
during measurements of vascular outcomes could have affected the results.  For example, MCA 
CBFv is known to decrease during stages 2-4 of sleep [184]. It is difficult to assess the level of 
sleepiness of participants as it is common for individuals to doze off during rest and close their 
eyes during vascular procedures. However, it is recommended that vascular testing be performed 
while participants are awake [59, 63].  Some participants appeared to be sleepy during rest but 
opened their eyes when testing procedures began. Other participants did not appear to be sleepy 
but verbally expressed they felt sleepy or could fall asleep. Measures of sleepiness during testing 
were not obtained; thus, a limitation is that the percentage of time during which participants were 
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sleepy or asleep cannot conclusively be determined. It was documented that one participant fell 
asleep during TCD measurements and one participant fell asleep prior to vascular testing. 
However, removing these participants in a sensitivity analysis did not change the results. Future 
research should also refine experimental protocols to minimize the effect of potential sleepiness 
on vascular measures created by the experimental arrangement as this could affect results. This 
might include time of day and a standardized stimulus during rest protocols. Furthermore, 
sleepiness should be evaluated during the protocol. 
5.6 CONCLUSIONS 
Although there is accumulating evidence suggesting that aerobic exercise improves 
cerebrovascular hemodynamics, few studies have evaluated the acute effects of exercise on CBF 
and even fewer on cerebral pulsatile flow. Based on our results, aerobic exercise does not 
improve cerebrovascular hemodynamics in the MCA within an hour of aerobic exercise. 
Additionally, our results suggest a 10- and 30-minute bout have differential effects on PWV and 
do not support studies reporting acute decreases in PWV following a 30-minute exercise bout. 
Important areas for future research include assessment of cerebrovascular hemodynamics at 
more frequent time points and beyond 60 minutes post-exercise, in different cerebral regions and 
vessels, and its relationship to concomitant changes in arterial stiffness. In addition, elucidating 
mechanisms and effects of shorter versus longer aerobic exercise bouts on arterial stiffness 
warrants further research. 
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SCREENING FORM:  
 
1. Thank you for your interest in our program.  My name is __________ and I would briefly like 
to tell you about this research program. 
 
2. Procedure for Describing the Study and Obtaining Verbal Consent to Conduct the 
Phone Screen:  A description of the study will be read to participants, and this description 
includes important components of the informed consent process (see attached script).  
Individuals who express an interest in participating in this study will be told the following to 
obtain verbal consent:   
• Investigators Component of Informed Consent:  The Exercise for Healthy Arteries 
Study is being conducted by Sophy Perdomo under the supervision of Dr. Bethany 
Barone Gibbs at the University of Pittsburgh. 
• Description Component of Informed Consent: The purpose of this randomized, 
cross-over study is to evaluate whether exercise has acute benefits on blood flow in the 
brain and on the stiffness of your blood vessels. Participants will attend one screening 
visit and 3 experimental sessions: one where you will be asked to sit and watch a 
preselected National Geographic Channel series for 30 minutes, another where you will 
watch the same documentary series for 20 minutes and then exercise for 10 minutes 
and one where you will exercise for 30 minutes. After each condition, we will measure 
the blood flow in your brain and how stiff your blood vessels are 2 times over a 1-hour 
period. The order of these experimental visits will be assigned by a process similar to 
flipping a coin We are interested in recruiting 15 middle aged adults, who can exercise 
safely and are interested in participating. If you are found to be initially eligible for the 
study after this phone screening, we will invite you to the laboratory near the University 
of Pittsburgh Oakland Campus for an orientation visit where the full details of the study 
will be described to you, you will have a chance to ask questions, and, if you are 
interested in participating, you will be asked to sign a consent document. Next, we will 
measure your height, weight, blood pressure, and arm and waist circumference and ask 
you to complete a detailed medical history and questionnaires about your level of 
physical activity. We will also ask you to walk briskly on the treadmill to determine at 
what speed you will start the exercise sessions. In preparation for the screening visit, we 
will ask you to abstain from physical activity, caffeine, nicotine and alcohol prior to the 
screening visit. It is possible that after this screening session, you may not be eligible to 
participate in the study. If your blood pressure readings are 140/90 or higher, you will 
need to obtain permission from your PCP to participate. If you are determined to be 
eligible after this screening visit, we will schedule a time for you attend your first 
experimental session. These sessions will take place in the afternoon and last 
approximately 2.5 hours.  There should be 48 hours between each session. We will ask 
that for these visits you wear shorts or pants as we will be testing a blood vessel near 
the groin. We will also ask that you wear comfortable clothing for the exercise sessions. 
You may want to bring food with you as we will ask you to fast 4 hours prior to and 
during each 2.5 hour experimental visit, a total of 6.5 hours between meals. The link 
between your study ID number and personal information will be kept in a secure location 
by the Principal Investigator. Upon the full completion of all study procedures, you can 
earn $100 for completing all 3 experimental sessions. Participation in this study is 
voluntary and you are free to discontinue at any time. 
 
If you are interested in participating in this study, I will need to ask you a few questions 
about your demographic background and questions about your physical health and 
medical history to determine if you appear to be eligible to participate in this study. It will 
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take approximately 5 minutes to ask you all of the questions. If we complete the 
interview, I will ask you for some specific information (your complete name, date of 
birth, and mailing address) so that we can contact you regarding your participation in 
this study.  I will then schedule you to attend a session that will explain all of the 
procedures of this study in greater detail.’ 
 
“Your responses to these questions are confidential, and all information related to your 
health history or current behaviors that you are about to give me will be destroyed after 
this interview if you are found to be ineligible.” 
 
Do you have any questions related to any of the information that I have provided to 
you? Staff member will answer any questions or will defer these questions to the 
Principal Investigator or Co-Investigator when appropriate prior to proceeding.  If the 
individual would like to think about their participation prior to proceeding with the Phone 
Screen, they will be provided with the telephone number that they can call if they decide 





































• Voluntary Consent Component of Informed Consent:  “Do I have your permission to ask 
you some questions about yourself?” 
 
If “YES” indicate the participant’s agreement with this statement on the top of the next 
page, sign your name and date the form, and then complete the Phone Screen. If “NO”, 
thank the individual for calling and do not complete the Phone Screen.  
 




The caller gives verbal permission to conduct the Phone Screen:    
 _____   YES ______  NO 
 
Verbal Assent was given to: 
 
___________________________________________________ 




Date Verbal Assent was given: 
 
 
Eligible based on telephone screening:     Yes  No  




Discontinue Phone Screen if Participant Does NOT Meet Eligibility Criteria for a Question. 
(bolded choices indicate eligible)  
1. How old are you?         (35-59 years old) 
 
2. Are you able to come to our research facilities on 4 separate occasions?    Yes   No 
 
3. Are you willing to watch National Geographic content?      Yes   No 
 
4. Are you currently being treated for any medical condition that could limit your ability to walk on a 
treadmill such as cancer, end stage renal disease, or severe arthritis?    Yes   No 
If yes, describe: ___________________________ 
 
5. Do you or have you ever had heart disease or cerebrovascular disease (such as stroke) ?  Yes   No 
 
6. Have you ever been told by a doctor or medical professional that you should not engage in physical activity 
for any reason?  Yes   No 
 
7. Has your doctor ever said that you have a heart condition and that you should only do physical activity 
recommended by a doctor?  Yes   No 
 
8. Do you feel pain in your chest when you do physical activity?  Yes   No 
 
9.  In the past month, have you had chest pain when you were not doing physical activity?  Yes   No 
 
10. Do you lose your balance because of dizziness or do you ever lose consciousness?  Yes   No 
 
11. Do you have a bone or joint problem (for example, back, knee or hip) that could be made worse by a 
change in your physical activity?  Yes   No 
 
12. Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart 
condition?        Yes   No 
 
13. Do you know of any other reason why you should not do physical activity?  Yes   No 
 









15. Would you be able to abstain from moderate-to-vigorous physical activity, caffeine, nicotine, and alcohol 
for 24 hours prior to each experimental session at out laboratory?  Yes   No 
 
16. Would you be able to fast for 4 hours prior to and then during each 2.5-hour experimental condition at our 
laboratory?          Yes   No 
 
17. (for females) Are you currently pregnant, trying to get pregnant, or plan to get pregnant in the next 2 




Contact Tracking Form 
 
 
** THIS PAGE IS COMPLETED ONLY IF THE RESPONDANT APPEARS TO 
QUALIFY FOR PARTICIPATION IN THIS STUDY. ** 
 





Street Address: ________________________________________________ 
 
City: _____________________________   State: ___  Zip Code:________ 
 




OFFICE USE ONLY:  
 
Eligible:     Yes   No  
Invited to Orientation:  Yes   No  




























PAFFENBARGER EXERCISE HABITS QUESTIONNAIRE 
1.  Was there anything about the past week that made exercising especially different for you in terms of extended illness, injury, or vacation?  
 1Yes If “YES”, please complete this questionnaire about the previous “typical” week that occurred within the past 30 days. 
 2No  If “NO”, please complete this questionnaire about this past week. 
  
2.  First, we are interested in the number of flights of stairs you climbed on average EACH DAY in this week.  We only want to know the 
number of flights you climb going UP - not down.   
*When answering this question, One Flight of Stairs = 10 steps if you know the number of steps. 
  _____FLIGHTS PER DAY 
 
   
3.  We want to know how much time you spent this past week brisk walking for exercise or transportation.  We are interested in bouts of 
walking that were at least 10 continuous minutes in duration. This would include walking outside, at an indoor facility, or on a treadmill. 
 
3a. How many days this week did you walk briskly for the purpose of exercise or transportation for at least 10 continuous minutes outside, at 
an indoor facility, or on a treadmill?   
_____ DAYS IN THE PAST WEEK 
 
3b. On these days in which you walked briskly at least 10 continuous minutes, on average, how many minutes per day did you walk briskly?   
                                                                 _____ MINUTES  PER DAY 
      
4.  Were there any other sport, fitness, or recreational activities in which you participated during the past week?  We are interested only in 
time that you were physically active while performing the activity.  
*Note:  Do not include “occupational” or “job related” activity as these are not considered to be sport, fitness, or recreational activity.  
Household activities such as cleaning, laundry, yard work and gardening are NOT to be included here as they are not considered to 
be a sport, fitness, or recreational activity. 
 
Sport, Fitness, or Recreation Days per Week Average Time per Day 
a. ____ _____ Minutes per  Day 
b. ____ _____ Minutes per Day 
c. ____ _____ Minutes per Day 
 
5. Would you say that during the past week (the week used for questions 2-4) you were: 
  less active than usual    
  more active than usual    
  about as active as usual 
 
   
6.  In general, at least once per week, do you engage in regular activity similar to brisk walking, jogging, bicycling, etc. long enough to work up 
a sweat, get your heart thumping, or get out of breath? 
  Yes If “Yes”, please indicate the number of days per week: ___ 




7. In general, how hard do you work while you are physically active? 
                                   take it easy without breathing hard or sweating 
                                   little hard breath and sweating 















































Workload Estimation Form 
 
Participant ID: _________________  Date_______________ 
 
Termination Heart Rate: ___________ bpm (70-75% of Age-Predicted Max Heart Rate) 
Time 
(minutes) 
Speed (mph) % Grade 
Heart Rate 
(bpm) 
0:00 - 1:00 2.4 0.0%  
1:01 - 2:00 2.6 0.0%  
2:01 - 3:00 2.8 0.0%  
3:01 - 4:00 3.0 0.0%  
4:01 - 5:00 3.2 0.0%  
5:01 - 6:00 3.4 0.0%  
6:01 - 7:00 3.4 0.5%  
7:01 - 8:00 3.4 1.0%  
8:01 - 9:00 3.4 1.5%  
9:01 - 10:00 3.4 2.0%  
10:01 - 11:00 3.4 2.5%  
11:01 - 12:00 3.4 3.0%  
12:01 - 13:00 3.4 3.5%  
13:01 - 14:00 3.4 4.0%  
14:01 - 15:00 3.4 4.5%  
15:01 - 16:00 3.4 5.0%  
16:01 - 17:00 3.4 5.5%  
17:01 - 18:00 3.4 6.0%  
18:01 - 19:00 3.4 6.5%  
19:01 - 20:00 3.4 7.0%  
20:01 - 21:00 3.4 7.5%  
21:01 - 22:00 3.4 8.0%  
22:01 - 23:00 3.4 8.5%  
23:01 - 24:00 3.4 9.0%  
24:01 - 25:00 3.4 9.5%  
25:01 - 26:00 3.4 10.0%  
26:01 - 27:00 3.4 10.5%  
27:01 - 28:00 3.4 11.0%  
28:01 - 29:00 3.4 11.5%  
29:01 - 30:00 3.4 12.0%  
Termination 
Time: ___:___ 
   
 
 
Starting Speed (mph) and % Grade: _____________
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Example Experimental Session Timeline 
0:00 Participant is greeted 
Participant is walked to room 224 
     Adherence to instructions (abstaining from exercise 24hr, nicotine 
and caffeine 12 hrs and a 4hr fast) is confirmed and recorded 
Participant is prompted to use restroom 
Participant puts on heart rate monitor 
0:05   Supine rest begins 
0:15   Duplicate supine blood pressures are measured 1 min apart (baseline) 
0:18 TCD 
0:28 PWV 
0:33 Transition from supine position to computer  
0:36 Begin watching documentary series 
1:06 End watching documentary series/Transition to supine position 
1:09 Participant lays in supine position 
1:19 Supine rest begins 
1:29 Duplicate supine blood pressures are measured 1 min apart (30-minute post) 
1:31 TCD 
1:41 PWV 
1:42 Participant remains supine 
1:49 Supine rest begins 
1:59 Duplicate supine blood pressures are measured 1 min apart (60-minute post) 
2:01 TCD 
2:11 PWV 
2:21 Participant is finished 
Participant is prompted to use restroom 
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